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ABSTRACT 
 
 
Sex Differences in Anxiety: 
 
Testing a Prenatal Androgen Hypothesis Using Behavioral  
 
and Physiological Markers.  (May 2006) 
 
Milagros Evardone, B.S., University of Florida 
 
Chair of Advisory Committee: Dr. Gerianne M. Alexander 
 
 
The majority of studies examining the role of prenatal androgens on abnormal 
behavior have focused on developmental disorders showing large male to female ratios 
(i.e., autism and Tourette’s Syndrome).  There is a scarcity of research examining the 
role of prenatal sex hormones on female-linked disorders or disorders showing adult 
onset.  This study is the first to evaluate the organizational and activational influences of 
sex hormones on adult levels of anxiety, while simultaneously examining previously 
reported hormone-behavior associations.  In addition, this study explores the relation 
between prenatal and postnatal sex hormones and two other female-linked disorders, 
depression and borderline personality.  As part of this study, participants (n = 110) 
completed a battery of psychopathology questionnaires, gender role measures, and 
spatial/cognitive tasks.  Prenatal androgen levels were indirectly measured by means of 
the index to ring finger ratio (2D:4D), and testosterone and estrogen levels were 
obtained from saliva samples.  Results replicate previously reported sex differences in 
anxiety and gendered behavior and confirm various hormone-behavior associations.  
More importantly, results provide preliminary evidence for the organizational role of 
 iv
prenatal androgens in two female-linked conditions, anxiety and borderline personality.  
Individuals with a higher (i.e., more feminine) 2D:4D reported greater symptoms of trait 
anxiety and borderline personality (i.e., affective instability), and this effect appeared to 
be strongest in males. 
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INTRODUCTION 
 National epidemiological surveys in various countries consistently demonstrate a 
higher prevalence of anxiety disorders in women than in men (Horwath & Weissman, 
1997).  According to reviews, females are two times more likely than males to develop 
an anxiety disorder during their lifetime (Bijl, De Graaf, Ravelli, Smit, & Vollebergh, 
2002; Halbreich, 2003; Pigott, 1999; Pigott, 2003; Reich, 1986; Shear, Feske, & Greeno, 
2000; Weissman, 1988).  Panic disorder (PD) with and without agoraphobia, simple 
phobia, post-traumatic stress disorder (PTSD), and generalized anxiety disorder (GAD) 
show the strongest female vulnerability (Bijl et al., 2002; Carter, Wittchen, Pfister, & 
Kessler, 2001; Fredrikson, Annas, Fischer, & Wik, 1996; Gavranidou & Rosner, 2003; 
Pigott, 1999; Pigott, 2003;Wittchen & Hoyer, 2001; Wittchen, Zhao, Kessler, & Eaton, 
1994).  Obsessive-compulsive disorder (OCD) and social phobia show less of a sex 
difference, although these two conditions continue to affect more females at a ratio of 
1.5 to 1 (Furmark et al., 1999; Pigott, 1999; Pigott, 2003).  Children and adolescents 
display a similar pattern, with girls having a higher risk for separation anxiety, social 
phobia, simple phobia, and panic disorder, and boys showing a greater risk for 
obsessive-compulsive disorder (Weiss & Last, 2001; Weissman, 1988).  Females also 
report higher levels of non-clinical anxiety, and a trend for higher anxiety sensitivity 
than males (Armstrong & Khawaja, 2002). 
In addition to sex differences in the prevalence of anxiety disorders, sex and/or  
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gender also play an influential role in the individual’s symptoms and clinical course.   
Table 1 presents a summary of previous work reviewing the gender-divergent 
presentation of anxiety disorders.  With the exception of OCD, anxiety disorders appear 
to be not only more prevalent, but also more severe in females than in males.  As a rule 
of thumb, females are more functionally impaired, report a greater number and degree of 
symptoms, and have added comorbid diagnoses.  Strong support is, thus, available for a 
sex difference in anxiety.  The question left to answer is why women seem to be at a 
greater risk.  It is this perpetual and enigmatic question that is at the core of the present 
study. 
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Table 1. Gender-divergent Presentation of Anxiety Disorders 
 Female to Male 
Ratio 
Symptoms Comorbidity Severity Onset/Age 
Distribution  
GAD 
 
(Carter et al., 
2001; Pigott, 
1999; Pigott, 
2003; Wittchen et 
al., 1994; 
Wittchen & 
Hoyer, 2001; 
Yonkers, Bruce, 
Dyck, & Keller, 
2003) 
 
2:1 
 
 
 
 
 
 
---------------------- 
- Greater comorbid 
dysthymia in 
females 
- More chronic 
course in females 
 
- Higher rate of 
remission in 
males, followed 
by greater relapse 
at 8-year follow-
up 
- Increased rates in 
females over 45 
years old 
PD 
 
(Pigott, 1999; 
Pigott, 2003; 
Sheikh, Leskin, & 
Klein, 2002; 
Turgeon, 
Marchand, & 
Dupuis, 1998) 
 
2:1 – 3:1 - Greater number 
of individual 
symptoms 
reported by 
females 
 
-Females report 
greater 
agoraphobic 
avoidance, 
catastrophic 
cognitions, and 
fear of bodily 
sensations 
 
- Females report 
greater shortness 
of breath, 
faintness, and 
smothered feeling 
 
- Males report 
more GI 
complaints 
- Females have 
increased risk of 
comorbid 
agoraphobia, 
depression, GAD, 
simple phobia, 
alcohol abuse, 
social phobia, 
PTSD, and 
somatization 
disorder 
 
- Males have 
increased risk of 
alcohol abuse 
- Greater severity, 
functional 
impairment, and 
recurrence in 
females 
 
 
 
 
 
 
 
 
 
 
 
 
----------------------- 
 
PTSD 
 
(Gavranidou & 
Rosner, 2003; 
Pigott, 1999; 
Pigott, 2003; 
Yonkers & 
Kidner, 2002) 
 
2:1 - Most common 
trauma in females: 
sexual assault 
 
- Most common 
trauma in males: 
combat or 
physical attack 
- Greater comorbid 
somatoform pain 
disorder in females 
 
- Equal rates of 
GAD and major 
depression in males 
and females 
-  Longer, more 
chronic course 
expected in 
females 
- Males report a 
greater number of 
traumatic events, 
but women 
exposed to trauma 
are more 
susceptible to 
PTSD 
Simple Phobia 
 
(Fredrikson et al., 
1996; Pigott, 
1999; Pigott, 
2003) 
 
 
Animal phobias 
2:1 
 
Situational phobias 
4:1 
 
Mutilational/Health-
related 
1:1 
- Females report 
higher fear ratings 
in general 
 
- Most common 
phobia in females: 
animal 
 
- Most common 
phobia in males: 
fear of heights 
 
 
 
 
 
 
------------------------ 
 
 
 
 
 
 
--------------------- 
 
 
 
 
 
 
----------------------- 
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Table 1. Continued 
 
 Female to Male 
Ratio 
Symptoms Comorbidity Severity Onset/Age 
Distribution  
Social Phobia 
 
(Furmark et al., 
1999; Pigott, 
1999; Pigott, 
2003; Turk et al., 
1998) 
1.5:1 - Generalized 
subtype more 
common in 
females 
 
- Females report 
greater fears 
when: 
1) speaking before 
an audience 
2) speaking to an 
authority figure 
3) being observed 
as they work 
4) entering the 
room after others 
are seated 
5) becoming the 
center of attention 
6) having to speak 
up at a meeting 
7) disagreeing 
with others 
8) reporting to a 
group 
9) throwing a 
party 
 
- Males report 
greater fears 
when: 
1) using public 
bathrooms 
2) returning 
purchases 
- Greater comorbid 
agoraphobia in 
females 
 
- Greater substance 
abuse in men 
- Greater severity 
of symptoms in 
females 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
----------------------- 
 
 
OCD 
 
(Fontenelle, 
Marques, & 
Versiani, 2002; 
Lochner et al., 
2004; Pigott, 
1999; Pigott, 
2003; Yonkers & 
Kidner, 2002) 
1.5:1 - Males display 
more aggressive 
obsessions and 
compulsions and 
checking rituals 
 
- Females display 
more compulsive 
cleaning and 
washing rituals 
- Greater comorbid 
depression and 
eating disorders in 
females 
 
- Greater history of 
tic and bipolar 
disorders in males 
- Nonsignificant 
trends for longer 
course, decreased 
global 
functioning, and 
worsened 
outcome in males 
- Earlier onset in 
males 
 
- Increased rate of 
onset in females 
after menarche 
 
- Acute onset and 
episodic course in 
females 
 
Note.  GAD = Generalized Anxiety Disorder, PD = Panic Disorder, PTSD = Post-
traumatic Stress Disorder, and OCD = Obsessive-Compulsive Disorder  
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REVIEW OF LITERATURE 
Several theories aim to account for the robust sex difference in anxiety.  This 
research falls generally under three major categories: social factors/stressors, gender 
role, and biological explanations.   
Social Factors/Stressors 
Some researchers argue that women encounter more aversive and stress-
producing events during the course of their daily lives (Davis, Matthews, and Twamley, 
1999).  For instance, females are more likely to experience sexual, physical, and 
emotional abuse in comparison to males (Finkelhor, Hotaling, Lewis, & Smith, 1990; 
Young, Abelson, Curtis, & Nesse, 1997), while an increased history of childhood abuse 
can be found among individuals with anxiety disorders (Stein et al., 1996, Young et al., 
1997).  Logically then, if females have an increased risk for childhood abuse, and abused 
individuals are especially vulnerable to developing an anxiety disorder, then it follows 
that females should have an increased risk for anxiety.   
Structural gender inequalities favoring men are another explanation offered for  
increased rates of anxiety in females.  Controlling for education level, women continue 
to be paid less than men (Gibelman, 2003; O’Campo, Eaton, & Muntaner, 2004), enter 
less prestigious occupations (Cohen, 2004), and are perceived as having less power 
(Diekman, Goodfriend, & Goodwin, 2004).  This inferior social status is, according to 
some researchers, a constant and potent source of stress in the lives of women.  
 Other researchers seek to explain the sex difference in affective disorders by 
enumerating the multiple roles or “double burden” faced by women.  Females appear to 
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be in a constant struggle between their desire to be occupationally successful and their 
sense of duty as the lead caretakers of the family.  Although according to the role-
accumulation hypothesis, men and women with an increased number of social roles 
should experience less mental health problems (Sachs-Ericsson & Ciarlo, 2000), women 
who have multiple roles report feeling more anxious, distressed, and describe more 
somatic complaints (Simon, 1995).  These same women also describe more negative 
self-evaluations and feelings of inadequacy (Simon, 1995).  Distress is particularly 
evident in women who view work as independent of their family, with wife and mother 
as their primary roles and their job as an added responsibility (Simon, 1995).    
Nevertheless, other studies fail to support the association between multiple roles and 
higher rates of psychological disorders in women (Klumb & Lampert, 2004; Sachs-
Ericsson & Ciarlo, 2000; Thornton & Leo, 1992).   
 While it may be a likely contributor, an increased number of social stressors in 
women cannot sufficiently account for the gender difference in anxiety.  First, there is no 
specific link between stressors and anxiety.  Stressful events, such as childhood abuse, 
are associated with many forms of psychopathology, including depression, substance 
abuse, dissociative, and eating disorders (Chu, Frey, Ganzel, & Matthews, 1999; 
Léonard, Steiger, & Kao, 2003; MacMillan et al., 2001).  Second, if women experience 
more stress, then one might expect them to be more vulnerable to other stress-related 
disorders, such as substance abuse.  Yet, the latter is more common among males 
(Doherty & Szalay, 1996).  The issue of why, in females, some disorders (i.e., anxiety) 
are favored over others (i.e., substance abuse) remains unresolved. 
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Gender-role Orientation 
In an attempt to explain the gender difference in anxiety, the gender role 
socialization theory has received the most extensive support.  According to Bem 
(1981b), society prescribes a gender dichotomy of behaviors that children internalize and 
develop into a network of cognitive associations known as a gender schema.  Then, this 
cognitive schema serves as a funnel through which children filter all environmental 
stimuli, retaining information pertaining to their own gender and rejecting gender-
inconsistent information.  Through this process, individuals become sex-typed, with the 
more extensively sex-typed persons displaying an overactive gender schema and 
recalling more gender-congruent stimuli than androgynous individuals (Bem, 1981b).   
 Fodor (1974) was one of the early proponents of a link between gender 
socialization and female affluent disorders.  She theorized that women’s socially 
acquired roles as dependent, passive, and fearful creatures fostered a higher prevalence 
of phobias, particularly agoraphobia, within this gender.  In her view, phobias are an 
expression of hyper-feminine sex typing.  A similar perspective states that women are 
socialized to be interpersonally mindful and worry about others to the point of neglecting 
themselves.  This increased concern for others is, in turn, thought to increase women’s 
risk for psychological distress (Katz, Joiner, & Kwon, 2002).  Some researchers, in fact, 
argue that individuals high on femininity report higher levels of anxiety and that those 
adhering to the more traditional female role are especially susceptible (Perez Blasco & 
Serra Desfilis, 1997).   
 Other researchers state that it is not femininity that is relevant.  Rather, it is a lack  
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of masculinity that is associated with anxiety.  Individuals scoring high on feminine  
characteristics (i.e., dependence, passiveness) do not show greater agoraphobia, fear, or 
state anxiety (Arrindell, Kolk, Pickersgill, & Hageman, 1993; Chambless & Mason, 
1986; Eisler, Skidmore, & Ward, 1988; Ginsburg & Silverman, 2000).  Instead, adults 
and children reporting lower levels of masculine characteristics (i.e., assertiveness, 
aggression, dominance) also report the highest levels of state anxiety, agoraphobic 
symptoms, and fear, including social, bodily, and animal fears (Arrindell et al., 1993; 
Chambless & Mason, 1986; Eisler et al., 1988; Ginsburg & Silverman, 2000).  Only fear 
of sexual and aggressive scenes appears unrelated to decreased masculinity (Arrindell et 
al., 1993).  Given the above results, researchers theorize that masculinity, or the 
possession of positive male characteristics (i.e., instrumentality), is protective of female 
disorders. 
 Still other researchers find both masculinity and femininity to relate to anxiety.  
While feminine-typed individuals report the highest levels of fear, masculine-typed 
individuals report the lowest levels of fear both on the Wolpe Fear Inventory and the 
Fear Survey Schedule (FSS) (Carey, Dusek, & Spector, 1988; Dillon, Wolf, & Katz, 
1985).  Similarly, females who are more feminine or undifferentiated (i.e., low scores on 
masculinity and femininity) report higher levels of anxiety on the Clinical Anxiety Scale 
(CAS) than women who are more masculine or androgynous (i.e., high scores on 
masculinity and femininity) (Thornton & Leo, 1992).  It is possible, however, that 
feminine individuals score high on fear and anxiety measures because they are also more 
willing to express their emotions than masculine individuals (Gallacher & Klieger, 
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2001).  In one study, although individuals with a female gender role orientation reported 
higher levels of fear than masculine individuals, no behavioral difference in fear 
emerged in the Behavioral Avoidance Task (BAT) (Gallacher & Klieger, 2001).  
Incidentally, androgynous individuals reported lower levels of fear than masculine 
individuals on the FSS, perhaps suggesting that androgyny is somewhat protective of 
psychopathology (Gallacher & Klieger, 2001). 
 Excessive adherence to gender roles may also increase risk for anxiety.  For 
instance, one line of research argues that masculinity is not always favorable to 
psychological consequences.  Men with increased gender-role stress, those who show a 
strict commitment to the masculine gender role (Eisler & Blalock, 1991), are more likely 
to experience higher state and trait anxiety than men with a more flexible behavioral 
repertoire (Eisler & Skidmore, 1987).  Generally speaking, both males and females 
scoring high on masculine gender-role stress (MGRS) report increased levels of anger, 
fear, anxiety, depression, and poor health habits (Arrindell et al., 1993; Eisler et al., 
1988; McCreary et al., 1996).  Nevertheless, there may be a differential trend in the 
expression of emotional distress.  One study found that men who score high on MGRS 
are more likely to display anger, while females who score high on MGRS are more 
likely to display anxiety (Eisler et al., 1988).  However, McCreary et al. (1996) failed to 
replicate this sex effect. 
 Feminine Gender-role Stress (FGRS) may also prove as detrimental to mental 
health as MGRS. Women who score high on FGRS, those who adhere strictly to the 
female gender role, also report increased levels of depression (Gillespie & Eisler, 1992).  
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Given that depression occurs more frequently in women and is highly comorbid with 
anxiety disorders, these results may prove relevant in the study of anxiety.  One should 
note, however, that the association between FGRS and depression dissolves after 
controlling for gender-neutral stressors (Gillespie & Eisler, 1992).  The latter may 
perhaps serve as another example that it is not increased feminine characteristics (i.e., 
expressive traits) but decreased masculine characteristics (i.e., instrumental traits) that 
elicit the female disorders. 
 Although the relative contributions of femininity, masculinity, and gender-role 
stress require further clarification, gender socialization clearly exerts an effect on 
psychological health consistent with the observed sex differences in anxiety.  Even so, 
learned gender roles cannot fully account for the 2 to 1 female to male ratio in anxiety 
disorders.  For example, only 5% of the variance in fearfulness can be explained by 
gender-role orientation, suggesting that other factors are involved (Ginsburg & 
Silverman, 2000).  A more comprehensive theory considers environmental influences, 
such as gender-role and social stressors, in conjunction with biological predispositions  
(Yonkers & Kidner, 2002). 
Biological Explanations 
 Genetics. Researchers and clinicians have long observed the tendency for anxiety 
disorders to aggregate in families.  A meta-analysis of family studies shows a significant 
association between probands and first-degree relatives with PD, GAD, phobias 
(including simple, social, and agoraphobia), and OCD (Hettema, Neale, & Kendler, 
2001).  For probands with PD, 10% of first-degree relatives developed the disorder in 
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comparison to 2.1% of control relatives (Hettema et al., 2001).  Similarly, for probands 
with OCD, 8.2% of first-degree relatives developed the disorder in comparison to 2.0% 
of control relatives (Hettema et al., 2001).  This pattern of familial inheritance, in turn, 
lends support for a genetic component.   
 Twin studies consistently demonstrate a modest to moderate genetic heritability 
for anxiety disorders, with the remaining variance largely explained by non-shared 
(individual) environmental factors and little or no role for shared (familial) 
environmental factors (Hettema et al., 2001; Kendler et al., 1995).  Among the anxiety 
disorders, PD appears to have the highest genetic heritability, with 43% of variance 
attributed to shared genes and the rest attributed to non-shared experience (Hettema et 
al., 2001).  For GAD, the genetic contribution is smaller at approximately 32%.  A 
differential distribution by sex occurs for the remaining factors contributing to GAD.  
Only non-shared environment is important for males, while familial factors play an 
added role in female etiology (Hettema et al., 2001).  In addition, the genetic 
contribution estimate for phobias is 20-40% (Hettema et al., 2001; Kendler et al., 1995).  
There is also evidence for two genetic clusters within the anxiety disorders classification.  
PD and phobia form one genetic grouping, while GAD and depression share the second 
genetic factor (Kendler et al., 1995).  In fact, researchers argue that GAD and major 
depressive disorder are rooted in the same genetic locus but develop disorder-specific 
symptoms based on individual, or non-shared environmental factors (Kendler et al., 
1995; Kendler, Neale, Kessler, Heath, & Eaves, 1992).   
 Genetic heritability is not limited to the disorders themselves but also to what  
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researchers view as their precursors.  Childhood separation anxiety, which some believe  
leads to later PD or agoraphobia, has a 41% genetic heritability in females but no genetic 
history in males.  Non-shared factors and, to a lesser extent, familial factors determine 
the onset of separation anxiety in boys (Silove, Manicavasagar, O’Connell, & Morris-
Yates, 1995).  Likewise, genetics account for 45% and 30% of anxiety sensitivity and 
trait anxiety, respectively (Silove et al., 1995; Stein, Jang, & Livesley, 1999).  Genetic 
factors may, therefore, play a role in the development of the anxious or “neurotic” 
personality, which may then render the individual susceptible to clinical levels of 
anxiety. 
 With the advances in genomic technology and the apparent effectiveness of 
anxiolytic and antidepressant drugs, research has recently shifted to a search for specific 
genes involved in the etiology of anxiety.  Because monoamine oxidase inhibitor (MAO 
–A) antidepressants are often used for the treatment of anxiety disorders, the MAO-A 
gene on chromosome X is one possible culprit.  The MAO-A gene has been linked to 
OCD and PD in particular (Camarena et al., 2001; Deckert et al., 1999).  Interestingly, 
several sex differences emerge at the gene level.  For example, females with PD have a 
greater number of MAO-A high activity alleles than males (Deckert et al., 1999).  The 
opposite is true for OCD, where females have a higher frequency of low activity MAO-
A alleles than males (Camarena et al., 2001).  Sex differences also exist for the catechol-
O-methyltransferase (COMT) gene.  Females with OCD have a higher frequency of the 
low activity allele (Alsobrook et al., 2002).  Several other genes seem to affect the 
course of anxiety, but generating a list is beyond the scope of this research.  The MAO-
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A and COMT genes are listed here as an illustration of a possible sex-specific genetic 
contribution to the differences in anxiety. 
Neurobiology. While genetics do in fact seem to contribute a significant portion 
to the heritability of anxiety, the expression of a genotype requires the aid of biologic 
mechanisms.  Genes simply provide a groundwork, encoding information translated into 
neurochemical processes.  Research in this field primarily focuses on the actions of 
neurotransmitters and neurohormones, which show a link to anxiety in pharmacologic 
studies.  The most commonly implicated systems in the pathogenesis of anxiety include 
the noradrenergic, dopaminergic, serotonergic, opiate, glutamatergic, and GABA 
pathways (Brawman-Mintzer & Lydiard, 1997; Charney, Deutch, Krystal, Southwick, & 
Davis, 1993; Nutt, 2000; Nutt, Bell, & Malizia, 1998; Pigott 2003.)  In addition, other 
neurotransmitters, such as chatecholamine and cholecystokinin (CCK), appear to be 
involved (Brawman-Mintzer & Lydiard, 1997).  Evidence also points to a 
neuroendocrine dysregulation (Brawman-Mintzer & Lydiard, 1997; Charney et al., 
1993; Nutt, 2000; Pigott, 2003).  The hypothalamic-pituitary-adrenal (HPA) axis is 
responsible for the body’s normal stress response.  In the presence of threat, 
neurochemicals stimulate the production of corticotropin releasing factor (CRF), which 
then encourages the pituitary gland to secrete ACTH and the adrenal gland to produce 
cortisol, leading to autonomic arousal (Nutt, 2000).  However, a disruption in this chain 
of chemical events occurs in anxious individuals and yields an abnormal stress response 
(Brawman-Mintzer & Lydiard, 1997; Charney et al., 1993; Nutt, 2000.)  For example, 
individuals with PTSD have high glucorticoid and CRF levels (Charney et al., 1993).  
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HORMONAL EFFECTS ON ANXIETY 
Sex Hormones  
Neurotransmitter and neuroendocrine systems also appear to interact with sex 
hormones to influence anxiety symptoms.  Estrogen and progesterone, in particular, 
seem to play a modulatory role in anxiety-linked systems, including the GABAergic, 
noradrenergic, dopaminergic, and serotonergic complexes, as well as the HPA axis 
(Chrousos, Torpy, & Gold, 1998; Pigott, 1999; Seeman, 1997).  According to 
researchers, progesterone is both an anxiolytic and a mood destabilizer (Pigott, 1999).  
The anxiolytic effect of progesterone proceeds from its ability to increase GABA’s 
inhibitory function (Seeman, 1997).  Estrogen, on the other hand, is generally considered 
an anxiolytic (Pigott, 1999).  By enhancing dopamine, serotonin, and norepinephrine 
transmission, decreasing monoamine oxidase activity, exciting glutamate function, and 
upregulating the GABA/benzodiazepine receptor, estrogen helps decrease levels of 
anxiety (Pigott, 1999; Seeman, 1997; Smith, Adams, Schmidt, Rubinow, & Wasserman, 
2002).  It, nevertheless, remains to be seen exactly through what pathways estrogen and 
progesterone interact with neurotransmitters and neuropeptides to influence the  
pathogenesis of anxiety, and whether other sex hormones may be involved (i.e.  
androgens).  At the very least, estrogen and progesterone’s modulation of anxiety 
illustrates the ability of sex hormones to directly alter brain structures and influence 
behavior. 
 In general, sex steroids affect behavior in two ways: prenatal organization and 
postnatal activation.  A human fetus is phenotypically female until approximately the 6th 
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week of gestation (for review, see Alexander and Peterson, 2001).  At this time, if a Y 
chromosome is present, testes develop and begin to secrete androgens, causing a 
masculinization and defeminization of the body, including the brain.  If a Y chromosome 
is not present, then the fetus continues normal development as a female, forming ovaries 
and female genitalia (Alexander & Peterson, 2001, Breedlove, 1994).  The sexual 
differentiation of brain structures, through androgen levels in prenatal life, results in sex 
differences in a variety of behaviors (i.e., organizational effects). (Alexander & Peterson, 
2001; Breedlove, 1994; Rubinow & Schmidt, 1996).  In many instances, the expression 
of sex-linked behaviors depends on their “activation” by adult circulating levels of 
gonadal hormones (Alexander & Peterson, 2001; Breedlove, 1994; Rubinow & Schmidt, 
1996).  In fact, one sign of prenatal hormone involvement in behavior is the sensitivity 
of that behavior to postnatal hormone levels. 
Activational Effects of Sex Hormones 
Research examining the effects of gonadal hormones on anxiety concentrates 
heavily on the cognitive and behavioral effects exerted by post-pubertal sex hormone 
fluctuations (i.e., activational effects).  At puberty, there is an increase in sex hormone 
production, which catalyzes further sexual differentiation in the individual and 
establishes adult circulating levels.  Coincidentally, anxiety disorders typically onset in 
adolescence and young adulthood, periods falling on or shortly after puberty (Reich, 
1986; Yonkers & Kidner, 2002).  The onset of OCD in females, for instance, increases 
following menarche and surpasses the rate for males (Pigott, 2003).   These converging 
points provide preliminary evidence for the role of sex hormones in anxiety and warrant  
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their further study. 
Menstrual cycle studies offer one possible avenue for the study of gonadal 
hormones.  In retrospective reports, females consistently describe a worsening of anxiety 
symptoms in the premenstrual phase, when both estrogen and progesterone levels are 
elevated.  The above is true for several conditions, including individuals with panic 
attacks (Cameron, Kuttesch, McPhee, & Curtis, 1988), PD (Cook et al., 1990), OCD 
(Williams & Koran, 1997), and GAD in conjunction with premenstrual syndrome (PMS) 
(McLeod, Hoehn-Saric, Foster, & Hipsley, 1993).   However, prospective monitoring of 
anxiety symptoms across the menstrual cycle shows no significant premenstrual 
worsening of anxiety (Cameron et al., 1988; Cook et al., 1990).  Despite the null 
findings in prospective studies, individuals with PD viewing anxiety-provoking scenes 
show increased skin conductance during the premenstrual phase (Sigmon et al., 2000).  
Furthermore, lactate infusion in individuals with PMS produces panic attack frequencies 
similar to that of individuals with PD (Facchinetti, Romano, Fava, & Gernazzani, 1992). 
This lactate sensitivity illustrates a link between the premenstrual period and anxiety.  
Therefore, the true effect of the premenstrual period on anxiety continues to be an object 
of debate. 
 Contrary to a premenstrual increase in anxiety (i.e., a time of increased estrogen 
and progesterone levels), a second perspective attributes fluctuations in anxiety to the 
periodic drops of estrogen and progesterone (Seeman, 1997; Williams & Koran, 1997).  
Support for this theory comes from several sources.  A study of rats found that metestrus 
(i.e., low estrogen/low progesterone) females displayed more anxious behavior (i.e., 
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decreased time in the open arms of the plus-maze task) than females in the proestrus 
phase (i.e., high estrogen/ high progesterone) (Fernandez-Guasti & Picazo, 1990).  
Metestrus females were also less sensitive than proestrus females to the actions of 
anxiolytics (Fernandez-Guasti & Picazo, 1990).  Similarly, in people with PD, anxiety 
and panic attacks were more frequent following administration of 35% CO2 during the 
early follicular phase, when female hormones are fairly stable and minimal, than during 
the high estrogen/high progesterone mid-luteal phase (Perna, Brambilla, Arancio, & 
Bellodi, 1995). 
 If low levels of female gonadal hormones indeed increase anxiety responses 
(Seeman, 1997; Williams & Koran, 1997), then one would expect anxiety to decrease 
during pregnancy, when estrogen and progesterone increase dramatically, and to 
increase during the postpartum, when high levels of these hormones drop abruptly.  The 
pregnancy and postpartum literature partially supports this theory.  A general finding of 
retrospective studies that anxiety symptoms are reduced during pregnancy was not 
supported by the results of the only prospective study available (Altshuler, Hendrick, & 
Cohen, 1998).  A second review of PD and pregnancy reveals that an improvement in 
PD symptoms occurs in 41% of the pregnancies (Hertzberg & Wahlbeck, 1999).   
Although a mixed picture emerges from the literature, it may be that increased estrogen  
and progesterone levels during pregnancy may exert an anxiolytic effect on panic 
disorder (Altshuler et al., 1998).  This proposed anxiolytic effect, however, appears to be 
absent in OCD.  Instead, pregnancy seems to confer an increased risk for the onset and 
worsening of OCD, at least as reported in retrospective studies (for review, see Altshuler 
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et al., 1998).  One particular retrospective study found that 13% of female participants 
experienced an onset of OCD during pregnancy, and of those who already had OCD 
prior to pregnancy, 17% described a worsening at this time (Williams & Koran, 1997).  
Based on results for OCD and PD, no clear conclusion can be drawn on the effect of 
pregnancy hormones on anxiety.  Elevations in female hormones during this period 
appear to yield adverse effects for some disorders and protective effects for others, and 
the effects appear specific to the individual, with some people being more sensitive to 
hormones than others. 
 In contrast to studies of pregnancy and anxiety, results of postpartum studies 
generally support the hypothesis that anxiety increases with abrupt decreases in levels of 
female sex hormones (Seeman, 1997; Williams & Koran, 1997).  Panic disorder 
symptoms are consistently found to increase during the postpartum period (Altshuler et 
al., 1998).  For instance, a review of pregnancy studies found that 38% of pregnancies in 
these studies were associated with a worsening of PD during the postpartum period 
(Hertzberg & Wahlbeck, 1999).  Similarly, retrospective studies support an onset and 
increase in OCD symptoms during the postpartum period (Altshuler et al., 1998).  In one 
sample study, 29% of females with OCD prior to pregnancy reported worsening of 
symptoms during the post-partum (Williams & Koran, 1997).  Miscarriage, like the 
postpartum, also results in a dramatic drop in sex hormones (i.e., progesterone and 
estrogen).  Accordingly, it appears to heighten the risk for an initial or recurrent OCD 
episode.  Of women who miscarried, 3.5% developed OCD as compared to 0.4% of 
controls (Geller, Klier, & Neugebauer, 2001).  A similar trend emerges for PD following 
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miscarriage, although not statistically significant (Geller et al., 2001).  Overall, the 
postpartum literature and, to some extent, the pregnancy literature suggest that high 
levels of progesterone and estrogen may together prove protective against anxiety.  
Conversely, low levels of these hormones may have anxiogenic effects, likely through 
an interaction with neurotransmitters and the HPA axis (Chrousos et al., 1998; Pigott, 
1999; Seeman, 1997). 
Organizational Effects of Sex Hormones 
  From the earlier discussion, it appears that adult sex hormones, in combination 
with gender role socialization, varying social stressors, and genetics, account for a good 
portion of the sex difference in anxiety.  However, as activational effects are largely 
dependent on the prenatal sexual differentiation of the brain (Alexander & Peterson, 
2001; Breedlove, 1994; Rubinow & Schmidt, 1996), it is possible that prenatal levels of 
androgens, or the lack thereof, represent another significant risk factor in the female 
vulnerability to anxiety.  Relatively little research has been undertaken in this area, but 
what has been done suggests a contribution by prenatal hormones to sex differences in 
psychopathology (Alexander & Peterson, 2001). 
 In animal research, a sex difference in anxiety has been found for rats, but in the  
opposite direction as humans.  Male rats tend to display more anxious behavior than 
females, as measured by the amount of time spent in the open arms of the plusmaze task 
(Lucion, Charchat, Pereira, & Rasia-Filho, 1996; Zimmerberg & Farley, 1993).  This sex 
difference, in turn, appears to be mediated by the organizational and activational effects 
of gonadal hormones.  Male rats castrated at birth, resulting in low androgen levels and 
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abolishing a male organization of the brain, showed less anxious and more feminized 
behavior in adulthood (Lucion et al., 1996).  Because in humans, females are more at 
risk for anxiety than males, results based on animal research may be interpreted in a 
reverse manner.  One may hypothesize that males feminized by low levels of prenatal 
androgens will be more susceptible to anxiety. 
 Due to ethical constraints, manipulations of prenatal hormone environment 
cannot be undertaken in human research.  Knowledge of prenatal gonadal hormone 
effects on human behavior is primarily based on studies of individuals with hormonal 
abnormalities and studies examining physiological markers of prenatal androgen levels, 
such as the 2D:4D finger-length ratio (Sanders, Sjodin, & de Chastelaine, 2002), which 
is smaller in males than in females (Brown, Hines, Fane, & Breedlove, 2002; Rahman & 
Wilson, 2003).  In view of these constraints, few studies assessing the organizational 
role of androgens on sex differences in psychopathology exist.  Of the studies available, 
one examined the relation between the 2D:4D ratio and the development of abnormal 
behavior in preschool children (Williams, Greenhalgh, & Manning, 2003).  Girls with a 
low 2D:4D ratio (i.e., a more masculine (high) level of androgens in utero) expressed 
more hyperactivity and increased difficulties with social cognition, prosocial ability, and 
peer relationships (Williams et al., 2003).  Boys with a higher 2D:4D ratio (i.e., a 
feminine (low) level of prenatal androgens) displayed more anxious behavior than boys 
with a masculine ratio (Williams et al., 2003).  Similar results might be expected in adult 
men and women, suggesting a vulnerability to anxiety for feminine males.  In support of 
this hypothesis, the 2D:4D ratio also shows a positive correlation with neuroticism, as 
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measured by the Big Five personality test.  Individuals with a feminine (higher) finger-
length ratio score higher on the neuroticism factor (Fink, Manning, & Neave, 2004).   In 
as much as neuroticism is considered a dimensional precursor to anxiety, results suggest 
that individuals with a higher digit ratio will also report greater levels of anxiety.  
Additionally, though no relation was found between depression and 2D:4D by previous 
researchers (Martin, Manning, & Dowrick, 1999), a recent study found a positive 
association between digit ratio and trait depression in males (Bailey & Hurd, 2005).   As 
depression is a female-linked disorder that is highly comorbid with anxiety, a similar 
association might be expected between 2D:4D and anxiety.  Males with a feminine 
(higher) digit ratio would be predicted to be more anxious than males with a masculine 
(lower) digit ratio. 
The 2D:4D ratio also shows a correlation with autism, a developmental disorder  
primarily affecting males.  Children with autism, their parents, and siblings all seem to 
exhibit a low 2D:4D ratio indicative of high androgen levels prenatally (Manning, 
Baron-Cohen, Wheelwright, & Sanders, 2001).  The association between high prenatal 
androgen levels and a male-linked disorder, such as autism, is relevant here in that it 
suggests a possible association between low prenatal androgen levels and female-linked 
disorders (i.e., anxiety disorders). 
 Despite the scarcity of research linking prenatal sex steroids and abnormal 
behavior directly, pertinent knowledge can be drawn from studies assessing sex 
differences in normative behavior.  Visible differences in gendered behavior, including 
childhood toy and play preferences, have been repeatedly associated with prenatal 
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androgen levels.  The greater the androgen exposure, the more male-typical the behavior, 
and the lower the androgen levels, the more female-typical the behavior (Berenbaum & 
Hines, 1992; Leveroni & Berenbaum, 1998; Meyer-Bahlburg et al., 2004; Servin, 
Nordenström, Larsson, & Bohlin, 2003; Udry, 2000; Udry, Morris, & Kovenock, 1995).  
In particular, girls with Congenital Adrenal Hyperplasia (CAH), who have masculine 
levels of androgens prenatally, prefer boys’ toys (e.g. a ball or a car) over girls’ toys (e.g. 
a doll or tea set), report more male playmates, less maternal interest in infants, and aspire 
to more masculine professions (Berenbaum & Hines, 1992; Leveroni & Berenbaum, 
1998; Meyer-Bahlburg et al., 2004; Servin et al., 2003).  Females with a low 2D:4D ratio 
(high prenatal androgens) are also more likely to conform to a masculine gender role 
(Csathó et al., 2003). 
 Recall from the gender role discussion that a masculine sex-type is related to a 
lower risk for anxiety (Arrindell et al., 1993; Carey et al., 1988, Chambless & Mason, 
1986; Dillon et al., 1985; Eisler et al., 1988; Thornton & Leo, 1992), unless it is 
accompanied by a rigid adherence to the male gender role characteristics (Eisler & 
Blalock, 1991; Eisler & Skidmore, 1987; Eisler et al., 1988).  Also, recall that a feminine 
sex-type is associated with an increased level of fear and anxiety (Perez Blasco & 
Desfilis, 1997; Carey et al., 1988; Dillon et al., 1985; Gallacher & Klieger, 2001; 
Thornton & Leo, 1992), although this association is not as strongly supported.  Now, if 
prenatal androgens predict gender role behavior and this, in turn, predicts vulnerability 
to anxiety, it is possible to think of prenatal sex steroids as indirect determinants of later 
anxious behavior.  It is also possible for prenatal sex hormones to exert direct effects on  
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brain structures, which are involved in the pathogenesis of anxiety disorders. 
 Prenatal androgens may also account for large sex differences in cognitive  
abilities, and this association could theoretically provide an avenue for the indirect  
measurement of prenatal androgen levels across and within the sexes.  Males, who have 
an increased amount of androgens in utero, (Breedlove, 1994; Rubinow & Schmidt, 
1996), demonstrate a consistent advantage on visuospatial (e.g. mental rotation) and 
targeting (e.g. throwing a ball at a target) tasks (Linn & Petersen, 1985; Watson & 
Kimura, 1991).  Females, who have lower levels of androgens than males in prenatal life 
(Breedlove, 1994; Rubinow & Schmidt, 1996) exhibit a small advantage on verbal 
fluency (Hyde & Linn, 1988) and a moderate advantage on memory tasks (e.g. spatial 
working memory and memory for object locations) (Alexander, Packard, & Peterson, 
2002; Duff & Hampson, 2001; Eals & Silverman, 1994).  Sex-linked tasks could, thus, 
serve as behavioral markers of prenatal androgen levels, such that individuals 
performing better on male-linked tasks would be expected to have high levels of 
androgens prenatally (e.g. CAH females) (Hampson, Rovet, & Altmann, 1998), and 
individuals performing better on female-linked tasks would be expected to have low 
levels of androgens. 
 As certain psychological disorders show a sexually dimorphic pattern, also 
theorized to emerge from differing levels of prenatal sex hormones, performance on sex-
linked tasks is believed to vary systematically across these disorders.  Recently, a 
correlation was established between several behavioral markers and Tourette’s 
Syndrome, a developmental disorder characterized by abnormal tic behavior and 
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showing a strong loading in males (Alexander & Peterson, 2004).  To test the hypothesis 
that a prenatal masculinization of the brain via high levels of androgens increased risks 
for tic disorders, this study found that affected females displayed a more masculine 
pattern of behavior. They reported more gender dysphoria and masculine play 
preferences and showed poor performance on location memory, but enhanced 
performance on mental rotation.  Results imply that females masculinized by high levels 
of androgens during the organizational stage of neural development are at a heightened  
risk for tic-related disorders (Alexander & Peterson, 2004). 
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PURPOSE AND HYPOTHESIS 
If prenatal sex steroids are involved in the pathogenesis of male-linked 
psychological disorders (Alexander & Peterson, 2004; Manning et al., 2001), then there 
is reason to believe that female-typical psychopathologies are also influenced by prenatal 
androgens.  In fact, recent findings suggest a link between depression and prenatal sex 
hormones (Bailey & Hurd, 2005).  This one study, however, is insufficient to justify an 
organizational effect on female-linked disorders.   As a further test of this hypothesis, 
this study examined the relation between prenatal androgens and another common 
female disorder, anxiety.  In the hopes of accumulating preliminary evidence that would 
later warrant the study of specific diagnoses, the present study examined the relation 
between non-clinical anxiety and phenotypic markers of prenatal androgen levels (i.e., 
2D:4D digit ratio), as well as several behavioral correlates, including gender identity, 
gender-type, play preferences, and spatial abilities.   
 Results were expected to replicate previous findings of greater anxiety in women 
compared to men and demonstrate the typical sex differences in play preferences, gender 
role bias, spatial abilities, and the 2D:4D ratio.  In view of the organizational effects of 
androgens on anxiety in rats and the indirect support of this association in humans, the 
primary hypothesis was that prenatal androgen levels, as measured by the finger-length 
ratio and indicated by the direction of performance on androgen-sensitive tasks, would 
be associated with a sexually-dimorphic vulnerability to anxiety.  Specifically, it was 
hypothesized that measures of anxiety would differ between groups of individuals with 
smaller and larger digit ratios.  It was also expected that within-sex performance on  
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gender-linked tasks would correlate with levels of anxiety.   
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METHODS 
Participants 
 As part of a larger study of sex differences in memory and spatial abilities, 110 
participants (58 male and 52 female) were recruited from Introductory Psychology 
courses at Texas A&M University and the community.  Those recruited through 
Introductory Psychology courses received two credits applied to their course work, and 
those recruited from the community were paid $15 for their participation.   
Materials 
Salivary Samples Questionnaire. To ensure participants’ compliance to sample  
collection restrictions, a short questionnaire was given asking participants about 
medication use, use of alcohol within 24 hours, consumption of a major meal within 60 
minutes, avoidance of highly acidic and sugar foods, brushing teeth within 3 hours, and 
consumption of dairy products within 30 minutes of sample collection.  
Handedness Questionnaire. Because handedness is associated with brain 
lateralization and may influence performance on sex-linked tasks (i.e., left handedness is 
more frequent among males), handedness was assessed by hand preference for writing. 
Menstrual Cycle Questionnaire. Female hormone fluctuations across the 
menstrual cycle may affect mood (Cameron et al, 1988; Cook et al., 1990; McLeod et 
al., 1993; Williams & Koran, 1997) and spatial task performance (Kimura & Hampson, 
1994).  To account for these possible activational effects, female participants completed 
a short questionnaire assessing the date of onset of their last menstrual period, average 
length of cycle, menstrual irregularities, any accompanying symptoms in the  
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premenstrual period, and current or prior oral contraceptive/hormone use. 
Vocabulary. A verbal test (Ekstrom & Stone, 1976) was given as a proxy 
measure of intelligence.  Participants were presented with a stimulus word followed by 
several response words.  They were asked to circle the word whose meaning was closest 
to the first and were given three minutes to complete the test. 
Digit Ratio. Consistent with previous research (Manning et al., 2001), digit ratios 
were derived by measuring (on scanned copies of right and left hands) the lengths of 
fingers (index and ring finger) in millimeters from the basal crease to the tip of the 
finger.  Two judges measured each hand copy using digital calipers, and an average 
measure was obtained across judges.  As right hand digit ratio is believed to be a more 
sensitive measure of prenatal androgens, only right hand 2D:4D was examined in the 
analyses. 
Salivary Samples. Research suggests that circulating levels of testosterone and 
estrogen may influence performance on sex-linked, spatial tasks (Kimura & Hampson, 
1994; Silverman, Kastuk, Choi, & Phillips, 1999) and contribute to anxiety symptoms 
(Cameron et al, 1988; Cook et al., 1990; Granger et al., 2003; McLeod et al., 1993; 
Williams & Koran, 1997).  Adult concentrations of testosterone also appear to have a 
negative correlation with the 2D:4D finger-length ratio, whereas estrogen appears to 
have a positive correlation (Manning, Scutt, Wilson, & Lewis-Jones, 1998).  Given the 
above findings, this study obtained two saliva samples from each participant, one at the 
beginning of the session and one at the end.  Time of sample collection was recorded to 
account for possible diurnal effects.  Saliva samples were then collected in small vials, 
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stored at – 80° C, and shipped to Salimetrics LLC for testosterone (both males and 
females) and estrogen (only females) assays. 
Gender Identity and Gender-Role Measures. Measures of gender identity and 
gender-role behavior included the Bem Sex-Role Inventory (BSRI; Bem, 1981a), the 
Pre-School Activities Inventory (PSAI; Golombok & Rust, 1993), the Occupation, 
Activities, and Traits – Attitudes and Personal Measures (OAT-AM & OAT-PM; Liben 
& Bigler, 2002), and the Draw-A-Person task (Zucker, Finegan, Doering, & Bradley, 
1983).  The BSRI consists of 60 items assessing masculinity and femininity as separate 
dimensions.  Scores on these two scales may be used to classify individuals into one of 
four gender role categories: masculine-typed, feminine-typed, androgynous, and 
undifferentiated.     
The PSAI is a 24-item measure assessing play preferences.  Individuals describe 
how frequently they play with certain toys (i.e., “guns”), engage in specific activities 
(i.e., “playing house”), and possess several characteristics (i.e., “enjoys rough and 
tumble play”).  Responses are given on a 5-point likert scale: N = “never”, HE = “hardly 
ever”, S = “sometimes”, O = “often”, and VO = “very often.” Items are scored on a 
range from 1-5, with a higher score indicating male-typical play preferences and a lower 
score indicating female-typical play preferences.  Although this questionnaire is 
designed for parents of children ages 2-5, it has been used in previous research with 
older populations to recall childhood play preferences.  Participants were thus instructed 
to respond as they would have when they were 3-7 years old.   
The OAT-AM is a 75-item questionnaire measuring gender attitudes towards  
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others.  It consists of three sections, each with 25 items, asking participants to describe 
whether men, women, or both sexes should do certain jobs (i.e., “secretary”, “plumber”, 
“florist”), activities (i.e., “fix a car”, “bake cookies”, “go to the beach”) or possess 
certain traits (i.e., “be emotional”, “be cruel”, “enjoy math”).  The OAT-PM, which 
measures gender typing of the self, also has 75 total items and three 25-item subscales.  
Participants are asked to describe their own occupational interests, involvement in 
activities, and personality characteristics. 
Finally, the Draw-A-Person task asks individuals to draw a person and then 
identify the sex of the figure.  In previous research, individuals with gender dysphoria 
(Zucker et al., 1983) and individuals exposed to atypical hormone levels in prenatal life 
(Zucker, Bradley, Oliver, & Blake, 1996) are less likely to depict same-sex figures. 
Psychopathology Measures. For a thorough assessment of anxiety symptoms, 
participants completed a battery of questionnaires including the Beck Anxiety Inventory 
(BAI; Beck & Steer, 1993), the State-Trait Anxiety Inventory (STAI; Spielberger, 
Gorsuch, Lushene, Vagg, & Jacobs, 1983), and the Anxiety Subscales of the Personality 
Assessment Inventory (PAI; Morey, 1991).  The BAI consists of 21 items assessing 
somatic and affective symptoms of anxiety (i.e., “feeling hot,” “fear of dying”, “scared”, 
“dizzy or lightheaded”).  Responses are given on a scale from 0-3, with 0 representing 
no symptom presence and 1-3 representing increasing symptom levels.  Scores on 
individual items are summed to provide an overall anxiety score.   
The STAI is composed of 40 items and 2 scales, 20 items per scale.  For the State 
Scale, participants are asked to describe how they are feeling “right now, that is, at this 
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moment.”  Responses are based on a 4-point scale ranging from 1 = “Not at all” to 4 = 
“Very Much So.”   On the Trait Scale, participants are prompted to describe how they 
“generally feel.”  Responses are based on a 4-point scale ranging from 1 = “Almost 
never” to 4 = “Almost Always.”  Half the items on each scale are scored in the positive 
direction and half in the opposite direction.  Scores on the 20 items are summed to 
provide an overall scale score.   
The PAI has three Anxiety Subscales (24 items total) measuring cognitive 
(ANX-C), affective (ANX-A), and physiological (ANX-P) components.  Test-takers 
must choose whether symptoms are “Totally False,” “Slightly True,” “Mainly True,” or 
“Very True” of them.  Scores on each item are weighted on a scale from 0-3.  Items in 
the ANX-C scale focus on ruminative worry and impaired concentration, whereas items 
in the ANX-A scale measure tension and fatigue caused by perceived stress.  In addition, 
the ANX-P scale evaluates somatic symptoms of anxiety (i.e., “shortness of breath” and 
“trembling of hands”).  The PAI also includes three Anxiety-related Disorders Scales (24 
items total) measuring obsessive-compulsiveness (ARD-O), phobias (ARD-P), and 
traumatic stress (ARD-T).  Responses are given on the same 4-point, weighted 
categories used in the Anxiety Subscales.  The ARD-O scale contains items assessing 
inflexibility, perfectionism, and the presence of intrusive thoughts and behaviors, while 
the ARD-P scale evaluates fear for common objects and situations (i.e., “fear of heights” 
and “enclosed spaces”).  Items on the ARD-T scale probe for a history of trauma and 
determine whether these events have reasonably altered the respondent’s life, or are 
presently causing distress. 
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 As a secondary interest, this study also examined two additional female-typical 
disorders: depression and borderline personality.  Symptoms of depression were assessed 
through the Beck Depression Inventory (BDI; Beck & Steer, 1987) and the Depression 
Subscales of the PAI (PAI; Morey, 1991).  Like the BAI, the BDI contains 21 items (i.e., 
“sadness”, “self-dislike”, “tiredness or fatigue”) with a response scale from 0 to 3.  Zero 
represents absence of symptom and 1-3 indicates increasing levels of the symptom.  
Scores on individual items are summed to provide a total depression score.   
 The PAI contains three depression subscales (24 items total) measuring cognitive 
(DEP-C), affective (DEP-A), and physiological (DEP-P) components.  Items on the 
DEP-C scale focus on the individual’s beliefs about worthlessness, inadequacy, and 
helplessness, whereas items on the DEP-A scale provide a general measure of life 
satisfaction and assess feelings of sadness and distress.  Lastly, the DEP-P scale is 
concerned with the vegetative symptoms of depression, such as the loss or gain in 
appetite and sleep.  Responses are provided using the same 4-point, weighted categories 
used for the anxiety scales (ANX and ARD). 
 Borderline Personality may represent an extreme form of normative gendered 
behavior (Skodol, 2000), which has previously been linked to prenatal sex hormones.  
The disorder’s symptoms appear to worsen with oral contraceptive use and during the 
high-estrogen phase of the menstrual cycle (De Soto, Geary, Hoard, Sheldon, & Cooper, 
2002).  This activational effect is also suggestive of a prenatal sex hormone involvement. 
Accordingly, this study examined borderline symptoms using the Borderline Features 
Scale of the PAI (PAI-BOR).  The PAI-BOR (24 items total) is sub-divided into four 
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subscales measuring affective instability (BOR-A), identity problems (BOR-I), negative 
relationships (BOR-N), and self-harm (BOR-S).  Response scales consist of four 
weighted alternatives similar to the anxiety and depression scales, (ANX, ARD, and 
DEP), with scores on each item ranging from 0-3.  The BOR-A scale measures 
emotional lability, whereas the BOR-I scale focuses on the individual’s lack of purpose 
and self-concept.  The BOR-N scale probes for a history of intense but unstable 
relationships, and the BOR-S scale examines impulsive behavior that could potentially 
result in self-destructive consequences. 
 It is also possible for mood state to be affected by completion of 
psychopathology measures and/or performance on spatial tasks.  For a quick assessment 
of mood, the Profile of Mood States (POMS; McNair, Lorr, & Droppleman, 1992) was 
administered at the start and end of each experimental session.  The POMS consists of 
64 mood-related adjectives.  Participants rate the applicability of each adjective to 
themselves using a 5-point scale ranging from 0 = “Not at all” to 4 = “Extremely.”  The 
first time the POMS-SF was administered, participants were asked to indicate how they 
had “been feeling during the past week including today.”  The second time it was given, 
participants were asked to rate how they “currently feel.” 
 Sex-Linked Spatial Tasks. Participants completed two female-linked tasks (spatial  
location memory, spatial working memory) and two male-linked tasks (mental rotation, 
targeting) in counterbalanced order (see Appendix A for task examples).  Memory for 
object locations was measured using the Silverman and Eals Location Memory Task 
(Silverman & Eals, 1992).  A stimulus card with an array of 27 common objects (i.e., 
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bird, flower, umbrella, iron, briefcase, teapot) was displayed for one minute followed by 
two response cards.  The first response card, measuring object identity, displayed the 27 
original objects plus 20 added objects.  Participants were asked to indicate which objects 
were new or had been added.  The second response card, measuring location memory, 
consisted of the 27 original objects.  However, the positions of seven pairs of objects 
were exchanged.  Participants were asked to indicate which objects had been moved.  
Response cards were displayed for a period of two minutes, or until the participant was 
finished.  Performance on both the identity and location task was measured using the 
following formula: 1 – [(omissions + commissions)/N], where N equals the total number 
of objects.   
Spatial working memory was assessed with a game, similar to the card game 
“Memory” (Duff & Hampson, 2001).  A 5 x 4 array made of beige-colored felt was 
mounted on the wall at participant’s eye level.  Ten pairs of colored dots (green, yellow, 
blue, orange, brown, red, black, gray, purple, and pink) were dispersed throughout the 
array in random order.  Dots were hidden beneath cutout flaps and could only be seen 
when participants lifted the flap.  To show participants the possible range of colors, 
sample dots of each color were displayed in a column to the right of the array.  
Participants were instructed to match the pairs of colored dots as quickly as possible, but 
only turning over two flaps at a time.  Before starting the task, the experimenter removed 
all sample dots from the side display.  Every time a participant matched a pair of dots, 
the experimenter placed the sample dot of that color back on the side display.  The latter 
allowed participants to keep track of colors they already matched and, hence, locations 
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they already searched.  Performance on this task was recorded by a video camera and 
viewed at a later time for coding purposes.  For each search attempt, experimenters 
recorded pairs of locations checked by participants using paper grids similar to the 5 x 4 
array.  Performance on this task was assessed by two dependent variables: total time 
required and total number of working memory errors (i.e., the number of times 
participants returned to already searched locations but did not produce a match plus the 
number of times they searched already matched locations). 
Spatial rotation ability was assessed via the Mental Rotations Test (MRT-A; 
Peters et al., 1995).  There are 24 items consisting of three-dimensional figures.  For 
each item, a sample block design is given, along with four possible rotated 
representations of the design.  The test-taker was asked to choose the two block patterns 
that matched the original figure.  Participants were allowed three minutes to complete 
the first two pages, followed by a two-minute break, and then another three minutes for 
the last two pages.  Performance on this task was based on the total number of correct 
items, those with both figures correctly identified. 
 To measure projectile throwing ability (Watson & Kimura, 1991), a target was  
constructed using a 36-inch-by-36-inch square of black felt.  A bull’s eye, made of white 
Velcro, was placed at the center of the square, 18 inches across and 18 inches vertically.  
Five ping-pong balls were also covered in Velcro, allowing them to adhere to the target 
upon contact.  Participants were given ten opportunities to hit the bull’s eye.  Distance 
from the center was measured for each trial and averaged across the ten trials to yield a 
throw accuracy score.  Higher scores indicate greater distances from the center, and thus  
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worse performance on targeting.  
Procedure 
 Upon signing the consent form, participants were provided a cup of water and 
instructed to rinse their mouth.  In accordance with saliva collection guidelines, the first 
salivary sample was collected 10 minutes after this procedure.  Participants then 
continued to complete the measures described above in the following order: 1) salivary 
samples questionnaire 2) handedness questionnaire, 3) POMS, 4) menstrual cycle 
questionnaire (females only), 5) vocabulary, 6) Draw-A-Person, 7) BAI, 8) BDI,  
9) PSAI, 10) PAI Anxiety, Depression, and Borderline Subscales, 11) OAT-PM and 
OAT-AM, 12) STAI, 13) BSRI, 14) female-linked tasks in randomized order (location 
memory and spatial memory), 15) male-linked tasks in randomized order (mental 
rotation and targeting), 16) second salivary sample, 17) POMS.  Following completion 
of the experimental session, hands were scanned into a computer and printed in color.  
Experimenters then fully debriefed and thanked individuals for their participation.  Each 
session lasted approximately 1 hour and 30 minutes. 
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RESULTS 
Participants’ Characteristics 
A total of 110 participants (58 male; 52 female) participated in the present study, 
and 97 (54 male; 43 female) completed the entire protocol.  However, some analyses are 
based on a smaller subset of participants, and these are listed where they occur.  Women 
and men were comparable in age, ethnicity, and in performance on the vocabulary test, a 
proxy measure of general intelligence (see Table 2). 
Preliminary Analysis 
The behavioral data were first screened for violations of multivariate 
assumptions: normality, linearity, homogeneity of variance, and multicollinearity.  
Although several of the dependent variables were skewed in their distribution, 
multivariate analyses of variance (MANOVA) performed on both transformed and 
untransformed data were remarkably similar in the direction and significance of results.  
For that reason, only the results of the analyses of untransformed data are summarized 
below.  First, the confirmatory analyses of previously reported sex differences and digit 
ratio effects on behavior are described, followed by the analyses of the novel, proposed 
associations between psychopathology and hormone levels.   
Confirmatory Analyses of Hormone-Behavior Associations 
Organizational Effects. Androgen levels in prenatal life are hypothesized to 
direct the sexual differentiation of behavior in human and nonhuman species and 
contribute to between-sex and within-sex differences in sex-linked behavior.  In this 
research, the proxy measure of prenatal androgen levels (digit ratio) was lower in males  
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Table 2.  Participants’ Demographic Characteristics 
 
  
Men 
(n = 58) 
 
 
Women 
(n = 52) 
Age, yrs 
 
19.67 (1.85) 20.69 (6.12) 
Ethnicity 
                    Hispanic/Latino 
                    Not Hispanic/Latino 
                    No response 
 
17.2% 
81.0% 
1.7% 
 
11.5% 
88.5% 
0% 
 
Race 
                   White/Caucasian 
                    Black/African-American 
                    Asian 
                    American Indian/Alaska Native 
                    No response 
 
 
81.0% 
5.2% 
3.4% 
0% 
10.3% 
 
 
84.6% 
3.8% 
9.6% 
0% 
1.9% 
 
Vocabulary, number correct 
 
24.05 (6.89) 
 
23.58 (8.15) 
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(M = .96, SD = .03) compared to females (M = .97, SD = .03) consistent with higher 
prenatal androgen levels in male development.  However, this sex difference in digit 
ratio did not reach statistical significance, F(1, 108) = 2.096, ns.  To consider the 
contribution of prenatal androgen levels to within-sex variability in behavior, high (more 
feminine) versus low (more masculine) digit ratio groups within each sex were created 
by a median split.  The resulting high digit ratio group consisted of 27 men and 19 
women.  The low digit ratio group consisted of 27 men and 24 women.  Analyses of 
prenatal hormone effects on behavior were then evaluated using separate 2 x 2 
MANOVAs, with sex (male, female) and the proxy measure of prenatal androgen levels, 
digit ratio (high, low), as grouping factors.   
Tables 3 – 5 present the means and standard deviations for women and men on 
measures of psychopathology, spatial ability, gender role behavior, and hormone levels, 
replicating the previously reported sex differences in these measures.  As expected, 
females generally reported higher levels of anxiety on the Anxiety-full scale (ANX) of 
the PAI, F(1, 93) = 7.834, p < .01,  and all three of its component scales: cognitive 
(ANX-C), F(1, 93) = 5.694, p < .025, affective (ANX-A), F(1, 93) = 9.726, p < .01, and 
physical symptoms (ANX-P), F(1, 93) = 4.812,  p < .05.  A significant main effect of 
sex was also found on the Anxiety-Related Disorders – Phobias Subscale (ARD-P) of 
the PAI, F(1, 93) = 7.007, p =.01, and a trend towards significance was found for the 
Beck Anxiety Inventory (BAI), F(1, 93) = 3.503, p < .10.  In contrast, no sex differences 
were found on state, F(1, 93) = .004, ns, or trait anxiety, F(1, 93) = 1.273, ns, and the 
Anxiety-Related Disorders Obsessions (ARD-O), F(1, 93) = 1.391, ns, and Trauma  
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Table 3.  Mean Scores (SD) on Measures of Psychopathology in Women and Men 
 
Means 
 
Task/ 
    Measure 
 
 
Sex    
Difference? Men 
(n = 54) 
Women 
(n = 43) 
 
 
Effect  
Size 
ANX 
Scale 
 
Yes** 45.61 (10.00) 51.22 (10.59) d = .54 
        ANX – 
        Cognitions 
        Subscale 
Yes* 46.81 (9.95) 51.56 (10.99) d = .45 
        ANX –  
        Affect 
        Subscale 
Yes** 43.96 (9.10) 49.61 (8.58) d = .64 
        ANX –  
        Physical Sx    
        Subscale 
 
Yes* 47.68 (9.57) 52.15 (12.12) d = .41 
STAI – State No 1.56 (0.59) 
 
1.55 (0.48) d = .01 
STAI –Trait No 1.73 (0.58) 
 
1.84 (0.45) d = .22 
BAI 
 
No 
 
7.63 (5.74) 10.26 (8.26) d = .37 
ARD 
Scale 
 
No 47.96 (9.89) 
 
50.81 (10.06) d = .29 
        ARD –  
        Obsessions  
        Subscale        
No 50.27 (9.42) 52.44 (10.21) d = .22 
        ARD –  
        Phobias 
        Subscale 
Yes* 44.52 (9.66) 49.38 (9.47) d = .51 
Anxiety 
Measures  
        ARD- 
        Traumas       
        Subscale 
 
No 49.92 (10.63) 49.83 (10.43) d = .008 
Borderline 
Measures 
BOR  
Scale 
 
No 48.85 (11.08) 50.27 (10.54) d = .13 
BDI No 7.93 (6.86) 
 
9.26 (7.47) d = .19 Depression 
Measures 
 DEP  Scale 
No 51.03 (12.35) 51.89 (11.96) d = .07 
 
Note.  ANX = Anxiety Scale of the Personality Assessment Inventory; STAI = State-Trait Anxiety 
Inventory; BAI = Beck Anxiety Inventory; ARD = Anxiety-Related Disorders Scale of the Personality 
Assessment Inventory; BOR = Borderline Personality Scale of the Personality Assessment Inventory; 
BDI = Beck Depression Inventory; DEP = Depression Scale of the Personality Assessment Inventory. 
*p < .05.  **p < .01. 
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Table 4.  Mean Scores (SD) on Measures of Spatial Ability and Gender Role Behavior 
in Women and Men Confirming the Expected Sex Differences in Behavior 
 
Means Task/ 
Measure 
 
Sex 
Difference? Men Women 
Effect  
Size 
Mental 
Rotation 
Yes*** 13.78 (4.61) 
n = 55 
9.06 (4.33) 
n = 50 
 
d = 1.06 
Targeting 
 
Yes*** 6.23 (1.78) 
n = 55 
9.53 (2.77) 
n = 50 
 
d = 1.41 
Spatial Memory -
Errors 
No 7.82 (9.71) 
n = 55 
5.60 (6.58) 
n = 50 
 
d = .27 
Spatial 
Tasks 
Location 
Memory 
No 0.74 (0.10) 
n = 41 
0.76 (0.11) 
n = 38 
 
d = .18 
PSAI 
 
Yes*** 76.26 (9.11) 
n = 54 
36.74 (15.60) 
n = 43 
 
d = 3.09 
OAT-PM – 
Masculine Score 
Yes*** 2.43 (0.32) 
n = 54 
2.12 (0.40) 
n = 43 
 
d = .87 
OAT-PM 
Feminine Score 
Yes*** 2.00 (0.25) 
n = 54 
2.46 (0.31) 
n = 43 
 
d = 1.65 
OAT-AM Yes*** 0.15 (0.15) 
n = 54 
0.05 (0.09) 
n = 43 
 
d = .78 
BSRI – 
Feminine Scale 
Yes*** 4.71 (0.56) 
n = 54 
5.27 (0.68) 
n = 43 
 
d = .89 
Gender Role 
Measures 
BSRI –  
Masculine Scale 
Yes* 5.53 (0.83) 
n = 54 
5.16 (0.65) 
n = 43 
d = .49 
Note.  PSAI = Pre-School Activities Inventory; OAT-PM = Occupations, Activities, Traits – Personal 
Measure; OAT-AM = Occupations, Activities, Traits – Attitude Measure; BSRI = Bem Sex-Role 
Inventory. 
*p < .05.  **p < .01.  ***p < .001. 
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Table 5.  Mean Scores (SD) on Measures of Hormone Levels in Women and Men 
 
Means Task/ 
Measure 
Sex 
Difference? Men Women 
 
Effect 
Size 
Right 2D:4D 
 
No 0.96 (0.03) 
n = 58 
 
0.97 (0.03) 
n = 52 
d =.28 Digit Ratio 
Left 2D:4D 
 
No 0.96 (0.04) 
n = 58 
 
0.96 (0.04) 
n = 52 
d =.17 
Salivary 
Testosterone 
(pg/mL) 
Average Testosterone Yes*** 230.99 (85.49) 
n = 58 
110.70 (51.05) 
n = 50 
d = 1.71 
Note.  ***p < .001. 
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(ARD-S), F(1, 93) = .008, ns, Subscales of the PAI.  Finally, males and females reported 
similar levels of depression, as measured by the Beck Depression Inventory (BDI), F(1, 
93) = .992, ns, and the Depression Subscales (DEP), F(1, 93) = .177, ns, of the PAI: 
affective (DEP-A), F(1, 93) = .025, ns, cognitive (DEP-C), F(1, 93) = .052, ns, and 
physical symptoms (DEP-P), F(1, 93) = 2.154, ns.  Males and females also did not differ 
on the Borderline Scale (BOR), F(1, 93) = .579, ns, and its component subscales: 
affective instability (BOR-A), F(1, 93) = .114, ns, identity conflict (BOR-I), F(1, 93) = 
.315, ns, negative relationships (BOR-N), F(1, 93) = 2.737, ns, and self-harm (BOR-S), 
F(1, 93) = .205, ns. 
 Consistent with previous research findings, males compared to females reported  
more “masculine” play and activities on all gender identity and gender role measures: 
PSAI, F(1, 93) = 252.574, p < .001, OAT-PM masculine scale, F(1, 93) = 17.515, p < 
.001, OAT-PM feminine scale, F(1, 93) = 64.843, p < .001, OAT-AM, F(1, 93) = 
13.018, p < .001, BSRI feminine scale, F(1, 93) = 18.402, p < .001, and the BSRI 
masculine scale, F(1, 93) = 5.506, p < .025.  Additionally, a large majority of males 
(49/54) drew male figures compared to female figures on the Draw-A-Person Task, 
whereas a smaller majority of females (24/43) drew female figures compared to male 
figures on that task  (χ2[df = 1] = 24.754, p < .001).  The analyses of spatial ability also 
showed the expected large male advantage in performance on the mental rotation task, 
F(1, 101) = 29.320, p < .001, and on the targeting task, F(1, 101) = 52.871, p < .001.  
However, this study failed to replicate sex differences on location memory, F(1, 74) = 
.029, ns, and spatial working memory, F(1, 101) = 1.873, ns, tasks which have 
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previously shown a slight to moderate female advantage (Alexander et al., 2002; Duff & 
Hampson, 2001; Eals & Silverman, 1994).   
 The main effect of digit ratio and the sex by digit ratio interaction effects showed 
no support for organizational effects of androgens on male-linked and female-linked 
spatial tasks.  However, individuals with a lower (i.e., more masculine) digit ratio 
reported more male-typical play preferences on the PSAI (M = 60.05, SD = 22.23), 
whereas individuals with a higher (i.e., more feminine) digit ratio reported more female-
typical play preferences (M = 57.29, SD = 24.54), F(1, 93) = 4.359, p < .05.  
Additionally, a significant interaction between sex and digit ratio groups emerged for the 
BSRI masculine scale, F(1, 93) = 10.510, p < .01, such that males with low digit ratio 
(M = 5.84, SD = .54) reported more male-typical traits as compared to males with high 
digit ratio (M = 5.21, SD = .95).  The differences between females with low digit ratio 
(M = 5.03, SD = .74) and females with high digit ratio (M = 5.34, SD = .47) were non-
significant.   
Correlations between digit ratio and sex-linked behavior across women and men 
showed only a negative relation between digit ratio and PSAI scores (r = -.230, p < 
.025), such that a higher (i.e., more feminine) 2D:4D ratio was associated with lower 
(i.e., more feminine) scores on the PSAI.  Within the group of men, more male-typical 
digit ratios were associated with more masculine-typical behavior as measured by the 
PSAI (r = -.285, p < .05), the BSRI (r = -.345, p < .025), and OAT-PM (r = -.271, p < 
.05).  In females, a higher (i.e., more feminine) digit ratio was associated with more 
gender congruent behavior, as measured by the OAT-AM (r = .309, p < .05) but, 
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unexpectedly, higher digit ratio was also associated with better spatial ability, as 
measured by the mental rotation task (r = .318, p < .025).   
Activational Effects. A repeated measures ANOVA showed no significant change 
in testosterone (male – F(1, 57) = .931, ns; female – F(1, 49) = 1.118, ns) or estradiol 
levels (female – F(1,46) = 2.304, ns) from time 1 to time 2.  For that reason, average 
hormone levels were calculated and used as the measure of testosterone and estradiol in 
the analyses of activational effects on behavior.  As expected, males had significantly 
higher levels of circulating testosterone than females, F(1, 104) = 75.926, p < .001.  Sex 
differences in estradiol levels were not determined as only female samples were 
analyzed for this hormone.  Additionally, the female sample included 14 oral 
contraceptive (OC)-users and 37 non-users.   OC-users were not included in the analyses 
of activational effects because synthetic steroid levels are not measured by the salivary 
assay. 
Bivariate correlations were conducted to examine previously reported 
associations between circulating hormone levels and spatial tasks, gender role behavior, 
and digit ratio.  In general, male behavior did not appear sensitive to testosterone levels, 
as androgen levels were unrelated to spatial task performance or gender role measures.  
However, multiple associations were found in females who were not taking oral 
contraceptives.  On spatial tasks, females with higher estrogen levels performed better 
on mental rotation (r = .417, p < .025) and committed less spatial memory errors than 
females with lower estrogen levels (r = -.356, p < .05).  A negative correlation was also 
found between testosterone and performance on location memory, such that lower 
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testosterone levels were associated with better performance (-.534, p < .01).  On gender 
role measures, testosterone correlated negatively to scores on the BSRI feminine scale (r 
= -.450, p < .025) and positively to the OAT-PM masculine scale (r = .358, p < .05), 
suggesting lower levels of testosterone among those with female-typical traits and higher 
levels among those with masculine-typical behavior.  No relation was found between 
hormone levels and digit ratio. 
Because previous researchers have reported menstrual cycle changes in mood, 
spatial task performance, and gender role behavior, female participants not using oral 
contraceptives were divided into three groups according to menstrual cycle phase: 
follicular (days 1-12 of cycle), ovulatory (days 12-16 of cycle), and luteal (days 17-
highest).  Separate MANOVAs with cycle phase as a factor were then conducted.  As 
might be expected, females differed significantly in state anxiety across the menstrual 
cycle, F(2, 28) = 3.757, p < .05, n = 31.  As shown by post-hoc tests, females in the 
luteal phase (M = 1.87, SD = .60, n = 12) reported significantly more state anxiety than 
females in the ovulatory phase (M = 1.23, SD = .23, n = 7).  Furthermore, a significant 
effect was found across the menstrual cycle for targeting accuracy, F(2, 32) = 3.936, p < 
.05, n = 35.  Unexpectedly, post-hoc tests show that females in the ovulatory phase (M = 
7.10, SD = 1.46, n = 7) performed the best in targeting as compared to females in the 
follicular (M = 9.88, SD = 1.92, n = 16) and luteal phases (M = 9.85, SD = 3.11, n = 12).  
The small sample size, however, limits the interpretation of these results. 
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Analyses of Proposed Associations Among Gender, Hormone Levels and 
Psychopathology  
Correlations Between Anxiety and Gender Role. Recall that anxiety was 
hypothesized to covary with gender role behavior, as previous research suggests that 
sexually dimorphic tasks share similar hormonal determinants.  Correlations calculated 
between anxiety measures and the four sex-linked spatial tasks were significant only for 
the two abilities that typically show a male advantage, (i.e., mental rotation and 
targeting).  Higher scores (i.e., better performance) on the mental rotation task were 
associated with lower levels of anxiety as measured by the STAI-trait (r = -.192, p < 
.05), the ANX-full scale (r = -.328, p = .001), ANX-C (r = -.311, p < .01), ANX-A (r = -
.378, p < .001), ANX-P (r = -.203, p < .05), and ARD-P (r = -.284, p < .01).  Similarly, 
lower scores on targeting (i.e., better targeting accuracy) were associated with lower 
levels of anxiety as measured by the STAI-trait (r = .213, p < .05), ANX-full scale (r = 
.225, p < .05), ANX-C (r = .238, p < .025), and ANX-A (r = .245, p < .025). 
Anxiety levels also covaried with other measures of gender role behavior, such 
that more female-typical behavior on the PSAI was associated with higher levels of 
anxiety as measured by the BAI (r = -.207, p < .05), ANX-full scale (r = -.306, p < .01), 
ANX-C (r = -.278, p < .01), ANX-A (r = -.316, p < .01), ANX-P (r = -.244, p < .025), 
and ARD-P (r = -.298, p < .01).  Similarly, higher scores on the BSRI masculine scale 
were associated with lower anxiety levels as measured by the STAI-trait (r = -.310, p < 
.01), ANX-full scale (r = .250, p < .025), ANX-C (r = -.208, p < .05), ANX-A (r = -.302, 
p < .01), and ARD-P (r = -.323, p = .001).  Finally, higher female-typical scores on the 
 48
OAT-PM feminine scale were associated with increased anxiety levels as measured by 
the ARD-full scale (r = .214, p < .05) and ARD-O (r = .313, p < .01), whereas higher 
scores on the BSRI feminine scale were associated with greater levels of anxiety on 
ARD-P (r = .245, p < .025). 
Organizational Effects. A series of MANOVAs, with sex and digit ratio as 
factors, were also conducted separately on anxiety, borderline personality, and 
depression measures.  Results from these analyses are summarized in Figures 1-5.  A 
significant main effect of digit ratio was found on STAI-trait, F(1, 93) = 4.587, p < .05, 
and ARD-P, F(1, 93) = 4.235, p < .05.  Regardless of sex, individuals with a high 2D:4D 
reported greater trait anxiety and phobia symptoms (M = 1.90, SD = .53; M = 48.57, SD 
= 9.97, respectively) than individuals with a low 2D:4D (M = 1.67, SD = .50; M = 44.96, 
SD = 9.47, respectively).  A difference between high and low digit ratio groups also 
approached significance on a third measure, ANX-C, F(1, 93) = 3.409, p < .10, such that 
individuals with high digit ratio reported greater cognitive symptoms of anxiety (M = 
50.73, SD = 11.03) than individuals with a low digit ratio (M = 47.27, SD = 10.09).   
   A significant main effect of digit ratio was also found for the BOR-full scale, 
F(1, 93) = 4.356, p < .05, and the BOR-A subscale, F(1, 93) = 9.371, p < .01, of the PAI.  
Individuals with a high 2D:4D reported greater borderline personality characteristics 
overall and greater affective instability, in particular, (M = 51.86, SD = 12.01; M = 
52.70, SD = 11.57, respectively) than did individuals with a low 2D:4D (M = 47.33, SD 
= 9.21; M = 46.15, SD = 9.21, respectively).  A trend towards significance was 
additionally found for the BOR-N subscale, F(1,93) = 3.530, p < .10.  Those individuals 
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Fig. 1.  Mean scores (+SD) on the State-Trait Anxiety Inventory-Trait Scale for low digit 
ratio (n = 51) and high digit ratio (n = 46) groups.  *p < .05. 
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Fig. 2.  Mean scores (+SD) on the State-Trait Anxiety Inventory-Trait Scale for males 
with low (n = 27) and high (n = 27) digit ratios and females with low (n = 24) and high 
(n = 19) digit ratios.  *p < .05.
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Fig. 3.  Mean scores (+SD) on the Anxiety-Related Disorders-Phobias Subscale of the 
Personality Assessment Inventory for low digit ratio (n = 51) and high digit ratio (n = 
46) groups.  *p < .05.  
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Fig. 4.  Mean scores (+SD) on the Borderline Personality Scale of the Personality 
Assessment Inventory for low digit ratio (n = 51) and high digit ratio (n = 46) groups.   
*p < .05.  **p < .01. 
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Fig. 5.  Mean scores (+SD) on the Borderline Personality-Affective Instability Subscale 
of the Personality Assessment Inventory for males with low (n = 27) and high (n = 27) 
digit ratios and females with low (n = 24) and high (n = 19) digit ratios.  *p < .05. 
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with a high digit ratio (M = 51.92, SD = 12.74) tended to report greater negative 
relationship symptoms than those with a low digit ratio (M = 47.91, SD = 9.71).   
No significant differences in high versus low ratio groups were found for the 
depression measures, though differences appeared to approach significance on the DEP-
A subscale of the PAI, F(1, 93) = 3.159, p < .10.  Across sex, individuals having a high 
2D:4D (M = 52.99, SD = 14.80) reported greater affective symptoms of depression than  
individuals with a low digit ratio (M = 48.34, SD = 10.81).   
Within-sex analyses using MANOVA with digit ratio as a factor revealed a 
significant difference in STAI-trait, F(1, 52) = 4.420, p < .05, for males and a close to 
significant difference in ARD-full scale, F(1, 41) = 3.877, p < .10, for females.  Males 
with a high digit ratio reported higher levels of trait anxiety (M = 1.89, SD = .58) than 
males with a low digit ratio (M = 1.57, SD = .55) and females with a high digit ratio 
tended to report greater symptoms of anxiety disorders (M = 54.09, SD = 10.47) than 
females with low digit ratio (M = 48.21, SD = 9.10). 
Similarly, a within-sex MANOVA with digit ratio as a factor revealed a 
significant difference in the BOR-A subscale for males, F(1, 52) = 5.517, p < .025, and a 
similar non-significant trend for females, F(1, 41) = 4.009, p < .10.  Males (M = 52.40, 
SD = 11.81) and females (M = 53.12, SD = 11.53) with a high digit ratio endorsed 
greater affective instability than males (M = 45.80, SD = 8.61) and females (M = 46.54, 
SD = 10.02) with a low digit ratio.  Further analyses of depressive symptomatology 
within males and females revealed no differences between high and low 2D:4D groups. 
Bivariate correlations between the continuous measure of digit ratio and  
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psychopathology measures across sex showed that digit ratio was positively associated 
with trait anxiety (r = .202, p < .05) on the STAI and with both the BOR-full scale (r = 
.206, p < .05) and the BOR-A subscale (r = .268, p < .01) of the PAI.  Individuals with a 
larger (i.e., more feminine) digit ratio tended to report greater anxiety and borderline 
symptoms on these measures.  However, within-sex correlations found a positive 
relation between digit ratio and STAI-trait (r = .260, p < .05) and between digit ratio and 
BOR-A (r = .299, p < .05) only for males.  Men with larger (i.e., more feminine) digit 
ratios reported greater trait anxiety and affective instability than men with smaller (i.e., 
more masculine) digit ratios.  Females’ 2D:4D ratios were not significantly associated to 
any measure of psychopathology.   
Activational Effects. Bivariate correlations reveal no significant association 
between circulating hormone levels and measures of psychopathology.  Average 
testosterone and estradiol levels appear unrelated to anxiety, depression, and borderline 
symptoms in males and in females not taking oral contraceptives.  Furthermore, as 
previous studies have shown a worsening of psychopathology across the menstrual 
cycle, separate MANOVAs with cycle phase as a factor were conducted for the anxiety, 
depression, and borderline scales of the PAI.  No differences were found between 
females in the follicular, ovulatory, and luteal phases on any of these measures.  Table 6 
provides a summary of these results. 
Regression Analyses. To test the relative contributions of sex, gender role 
measures, spatial task performance, and hormonal levels to anxiety and borderline 
personality, three separate hierarchichal regression analyses were conducted.  The ANX- 
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Table 6. Mean Scores (SD) on the Anxiety, Depression, and Borderline Personality 
Subscales of the Personality Assessment Inventory by Menstrual Cycle Phase in Females 
Not Taking Oral Contraceptives 
 
 
    Follicular  Ovulatory  Luteal  
                                                (n = 12)                       (n = 7)                (n = 12) 
 
 
ANX Scale           55.53 (11.47)            48.72 (13.04)          50.20 (11.17) 
 
ARD Scale           55.37 (11.15)            51.40 (10.23)          48.54 (9.44) 
 
DEP Scale           54.86 (12.31)            52.24 (8.56)          55.43 (15.59) 
 
BOR Scale           53.05 (11.40)            47.86 (13.16)           52.25 (9.89) 
 
Note. ANX = Anxiety Scale of the Personality Assessment Inventory; ARD = Anxiety- 
Related Disorders Scale of the Personality Assessment Inventory; DEP = Depression Scale of the 
Personality Assessment Inventory; BOR = Borderline Scale of the Personality Assessment Inventory. 
Follicular = day 1-12 of cycle; Ovulatory = day 12-16 of cycle; Luteal = day 17-highest. 
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full scale, ARD-full scale, and the BOR-full scale served as the dependent variables.  For 
each model, the BSRI masculine and feminine scales were entered at the first step, 
mental rotation and targeting scores were entered at the second step, digit ratio and 
testosterone levels were entered at the third step, and sex was entered at the fourth step.  
Hormone measures and sex were entered last to determine if they added any significant 
contribution beyond gender role behavior and spatial task performance. 
Results for the ANX-full scale regression analysis are provided in Table 7.  For  
this scale, inclusion of the BSRI masculine and feminine scales at the first step produced 
a significant Fchange, Fchange = 3.865, R2 = .078, p < .025.   Scores on the BSRI accounted 
for 7.8% of the variance in anxiety as measured by this scale.  At the second step, 
inclusion of the mental rotation and targeting scores also yielded a significant Fchange, 
Fchange = 4.870, R2 = .168, p = .01.  Male-linked tasks contributed an additional 9% of the 
variance in ANX-full scale scores.  Lastly, hormonal measures, Fchange = .349, R2 = .174, 
ns, and sex, Fchange = .155, R2 = .176, ns, did not appear to add significantly to the model.  
Examination of the beta weight sizes in the final model suggest that the BSRI masculine 
scale, β = -.22, p < .05, and mental rotation, β = -.25, p < .05, are the best predictors of 
anxiety.  In contrast, the variance in ARD-full scale and the BOR-full scale could not be 
significantly accounted by any of the four models or predictor variables. 
As this study found mean differences between low and high digit ratio groups on 
the BOR-A subscale, an additional regression analysis was conducted with BOR-A as 
the dependent variable.  Independent variables were entered in the same four-step 
fashion as above, and a summary of results is provided in Table 8.  At the first step, the  
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Table 7.  Hierarchical Regression Analysis Exploring the Contribution of Gender Role 
Measures, Spatial Ability, Hormone Levels, and Sex to Scores on the Anxiety Scale of 
the PAI 
 
 
Note.  BSRI = Bem Sex-Role Inventory. 
 
Step and Independent 
Variable 
 
B 
 
SE B 
 
β 
 
Step 1 
           BSRI masculine scale 
 
 
-3.53 
1.41 
 
 
1.38 
1.59 
 
 
-.26* 
.09            BSRI feminine scale 
Step 2 
           BSRI masculine scale 
           BSRI feminine scale 
           Mental Rotation  
 
-2.97 
.07 
-.54 
.44 
 
1.33 
1.60 
.23 
.42 
 
-.22* 
.005 
-.25* 
.11            Targeting 
Step 3 
           BSRI masculine scale 
           BSRI feminine scale 
           Mental Rotation  
           Targeting 
           2D:4D 
 
-3.05 
.31 
-.57 
.51 
13.30 
.01 
 
1.40 
1.65 
.24 
.46 
31.77 
.01 
 
-.22* 
.02 
-.27* 
.13 
.04 
.08            Average Testosterone 
Step 4  
           BSRI masculine scale 
           BSRI feminine scale 
           Mental Rotation  
           Targeting 
           2D:4D 
           Average Testosterone 
 
-2.98 
.16 
-.54 
.43 
13.20 
.01 
1.38 
 
1.42 
1.71 
.25 
.50 
31.92 
.02 
3.51 
 
-.22* 
.01 
-.25* 
.11 
.04 
.10 
.07 
 
           Sex 
R2  = .078 for Step 1 (p < .025); Δ R2 = .090 for Step 2 (p = .01);  
Δ R2 = .007 for Step 3 (ns); Δ R2 = .001 for Step 4 (ns). 
*p < .05. 
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Table 8.  Hierarchical Regression Analysis Exploring the Contribution of Gender Role 
Measures, Spatial Ability, Hormone Levels, and Sex to Scores on the Borderline 
Personality-Affective Instability Subscale of the PAI 
 
 
Step and Independent 
Variable 
 
B 
 
SE B 
 
β 
 
Step 1 
           BSRI masculine scale 
           BSRI feminine scale 
 
 
-1.46 
-2.42 
 
 
1.44 
1.66 
 
 
-.10 
-.15 
Step 2 
           BSRI masculine scale 
           BSRI feminine scale 
           Mental Rotation  
           Targeting 
 
-1.15 
-3.25 
-.26 
.37 
 
1.45 
1.74 
.25 
.46 
 
-.08 
-.20 
-.12 
.09 
Step 3 
           BSRI masculine scale 
           BSRI feminine scale 
           Mental Rotation  
           Targeting 
           2D:4D 
           Average Testosterone 
 
-.53 
-3.28 
-.29 
.20 
78.84 
.00 
 
1.48 
1.74 
.25 
.48 
33.56 
.02 
 
-.04 
-.20 
-.13 
.05 
.24* 
-.004 
Step 4  
           BSRI masculine scale 
           BSRI feminine scale 
           Mental Rotation  
           Targeting 
           2D:4D 
           Average Testosterone 
           Sex 
 
-.59 
-3.15 
-.31 
.27 
78.92 
-.003 
-1.13 
 
1.50 
1.80 
.26 
.53 
33.73 
.02 
3.71 
 
-.04 
-.20 
-.14 
.07 
.24* 
-.02 
-.05 
 
Note. BSRI = Bem Sex-Role Inventory. 
R2 = .031 for Step 1 (ns); Δ R2 = .029 for Step 2 (ns); Δ R2 = .056 
for Step 3 (p < .10); Δ R2 = .001 for Step 4 (ns). 
*p < .05.    
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 BSRI masculine and feminine scales accounted for a small but non-significant portion 
of the variance in affective instability scores, Fchange = 1.482, R2 = .031, ns.  At the 
second step, addition of mental rotation and targeting performance did not significantly 
improve the model, Fchange = 1.382, R2 = .060, ns.  However, inclusion of hormonal 
measures at the third step produced a near-significant Fchange, Fchange = 2.780, R2 = .116, p 
< .10.  Examination of individual beta weights suggests that digit ratio, β = .244, p < 
.025, is significantly contributing to the variance in BOR-A scores.  Finally, the addition 
of sex at the fourth step did not significantly improve the model, Fchange = .093, R2 = 
.117, ns. 
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DISCUSSION 
The results of the present study provide the first evidence that levels of 
androgens during prenatal life may influence the development of anxiety disorders, 
typically female-linked conditions.  Consistent with the primary hypothesis, a negative 
association was found between adult levels of anxiety and prenatal androgen levels as 
measured by both phenotypic markers (2D:4D) and behavioral correlates (i.e., gender 
role and spatial abilities).  In general, individuals with a higher digit ratio (i.e., more 
feminine or lower levels of prenatal androgens) reported greater levels of trait anxiety 
and phobic symptoms and a trend for greater cognitive anxiety symptoms than 
individuals with a lower digit ratio.  This novel finding is consistent with a previous 
report of an association between higher 2D:4D and neuroticism in adults (Fink et al., 
2004).   
The association between 2D:4D and anxiety in this research suggests further that 
the relationship between androgens and anxiety is strongest in males.  Specifically, men 
with 2D:4D indicating low androgen levels in prenatal life reported greater trait anxiety 
than men with 2D:4D indicating a high androgen environment.  Results are consistent 
with findings of an association between 2D:4D and anxious behavior in preschool boys 
(Williams et al., 2003) and with more feminized anxious behavior in castrated male rats 
(Lucion et al., 1996).  Only a non-significant trend emerged in females, such that women 
with lower prenatal androgen levels (higher 2D:4D) endorsed greater symptoms of 
anxiety disorders than women with higher prenatal androgen levels (lower 2D:4D).  This 
pattern of results suggests a protective role for prenatal androgens, particularly in males,  
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such that a “low androgen” environment in prenatal life is associated with anxiety  
vulnerability and a “high androgen” environment is protective against anxiety 
symptoms. 
In addition to the association between anxiety and 2D:4D, a relation was found 
between anxiety and male-linked, spatial tasks.  Individuals who performed better (i.e., 
more male-typical) on measures of mental rotation and targeting reported less anxiety 
than those who performed more poorly.  One possible explanation for this association is 
that increased anxiety impairs task performance.  Several other findings argue against 
this interpretation.  First, higher anxiety levels were not associated with poorer 
performance on female-typical tasks (i.e., location memory and spatial working 
memory).  Further, measures of state anxiety were also unrelated to performance on 
male-typical tasks.  A second possible explanation is that perceived failure or success on 
the tasks themselves may have produced changes in mood.  However, the design of the 
study precludes this interpretation as psychopathology measures were completed prior to 
spatial task performance.  Rather, it is believed that as sexually dimorphic behaviors, 
both anxiety and spatial tasks are organized by prenatal androgens.  As anxiety, location 
memory, and spatial memory are all female-linked behaviors, they are theorized to result 
from a low androgen environment.  Conversely, a high androgen environment is credited 
for the male advantage in mental rotation and targeting ability.  Given the direction of 
hormone-behavior associations, anxiety should correlate positively with other female-
linked behaviors  (i.e., location memory and spatial memory) and negatively with male-
linked behaviors (i.e., mental rotation and targeting).  Evidence for the latter was found  
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in this study. 
   Correlations were also found between anxiety and gender role behavior, and 
unlike results for spatial abilities, these were found for both the feminine and masculine 
gender role.  Masculine play preferences and gendered behavior were associated with 
lower trait anxiety, decreased symptoms on all three components of anxiety (cognitive, 
affective, and physical), and less phobic symptoms.  Conversely, more feminine-typed 
individuals reported greater anxiety disorder symptoms, specifically in relation to 
obsessions, compulsions, and phobias.  Results are consistent with the theory that both 
masculinity and femininity are contributors to anxiety.  While the masculine gender 
role’s emphasis on instrumental traits may be protective of anxiety (Arrindell et al., 
1993; Chambless & Mason, 1986; Eisler et al., 1988; Ginsburg & Silverman, 2000), the 
feminine gender role’s reliance on expressive traits may be conducive to this condition  
(Fodor, 1974; Perez Blasco & Serra Desfilis, 1997).   
Regression analyses provided further evidence of the relation between anxiety 
and behavioral correlates of prenatal androgen levels.  Male-typical behavior and spatial 
ability emerged as the best explanation of anxiety, such that higher scores on the BSRI 
masculine scale and better performance on mental rotation were associated with 
decreased anxiety symptoms.  Interestingly, hormonal measures and sex did not add 
significantly to the explanation of anxiety beyond the variables mentioned.  The absence 
of a direct contribution by testosterone levels and the proxy measure of prenatal 
androgens (2D:4D), however, does not preclude an organizational and activational effect 
on anxiety.  It is likely that the prenatal androgen contribution and the contribution by 
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sex were subsumed by the gender role measures and spatial tasks, as these have been 
strongly linked to prenatal androgens (Berenbaum & Hines, 1992; Hampson et al., 1998; 
Leveroni & Berenbaum, 1998; Meyer-Bahlburg et al., 2004; Servin et al., 2003; Udry,  
2000; Udry et al., 1995).   
In view of the novel findings of this research, it is important to note that this 
study also replicated previously reported sex differences in behavior.  As reported in 
epidemiological literature (Bijl et al., 2002; Halbreich, 2003; Pigott, 1999; Pigott, 2003; 
Reich, 1986; Shear et al., 2000; Weissman, 1988) and studies of non-clinical populations 
(Armstrong & Khawaja, 2002), females in this study reported significantly more anxiety 
symptoms than males.  The present study also replicated sex differences in gender 
identity and gender role behavior (i.e., play preferences) and supported the typical male 
advantage on mental rotation and targeting (Linn & Petersen, 1985; Watson & Kimura, 
1991).  Contrary to previous findings, however, (Alexander et al., 2002; Duff & 
Hampson, 2001; Eals & Silverman, 1994), no evidence was found for a female 
advantage on spatial working memory and location memory.  As expected, testosterone 
levels were significantly higher in men than in women, and as with previous research 
(Brown et al., 2002; Rahman & Wilson, 2003), males had a lower mean digit ratio than 
females, though the latter did not reach statistical significance. 
The present findings of hormone-behavior associations were also generally 
consistent with the results of previous investigations.  For instance, the present study did 
not find support for a negative association between 2D:4D and performance on male-
typical spatial tasks.  This is inconsistent with some research on 2D:4D showing a 
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negative correlation with mental rotation in men (Manning, 2002) but consistent with the 
lack of association between 2D:4D and spatial tasks found by other researchers 
(Coolican & Peters, 2003).  Furthermore, gender role has been linked in the literature to 
prenatal androgen levels (Berenbaum & Hines, 1992; Leveroni & Berenbaum, 1998; 
Meyer-Bahlburg et al., 2004; Servin et al., 2003; Udry, 2000; Udry et al., 1995) and to 
2D:4D, in particular (Csatho et al., 2003).  Similarly, this study found play preferences 
to be strongly related to 2D:4D, such that individuals with low (i.e., more masculine) 
digit ratios reported more masculine play preferences than individuals with high (i.e., 
more feminine) digit ratios.  Additionally, males with a low digit ratio tended to report 
more male-typical traits and occupation and activity preferences than males with a high 
digit ratio, whereas females with a high digit ratio reported more gender-typed attitudes 
than females with a low digit ratio.   
 Hormone levels in this study also appear to have activational effects on sexually  
dimorphic behavior, as previously found in the literature.  In contrast with the 
organizational effects, which were more evident in males, the effects of circulating 
hormones on behavior were exclusive to females.  Testosterone levels were not 
associated with gender role behavior, spatial task performance, or 2D:4D ratio in males.  
However, estrogen and testosterone associations were found in females who were not 
taking oral contraceptives.  As expected, females with higher estrogen levels performed 
better on spatial working memory as compared to those with lower estrogen levels.  This 
result is consistent with research showing that female performance on female-linked 
tasks is best during the ovulatory and mid-luteal phases, times of increased estrogen 
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levels (Kimura & Hampson, 1994).  Contrary to predictions, however, females with 
higher estrogen levels also had better performance on mental rotation, a task traditionally 
showing a male advantage.  This finding is at odds with menstrual cycle studies showing 
decreased performance on male-linked tasks during times of high estrogen (Kimura & 
Hampson, 1994).  In addition, higher testosterone levels in females were associated with 
worsened performance on location memory and more male-typical traits, activities, and 
occupations.  No relation was found between circulating estrogen and testosterone levels 
and 2D:4D ratio in females, adding to the mixed pattern of results in the literature.  
Although some studies have found a negative association between testosterone and digit 
ratio in men and a positive association with estrogen in both sexes (Manning et al., 
1998), other studies find no relation between circulating hormones and 2D:4D (Neave et 
al., 2003). 
 To evaluate activational effects across the menstrual cycle, this study also  
compared the behavior of females found in three different phases: follicular, ovulatory, 
and luteal.  Only females who were not taking oral contraceptives were included in these 
analyses.  Consistent with retrospective studies showing an increase in anxiety 
symptoms during the premenstrual phase (Cameron et al., 1988; Cook et al., 1990; 
McLeod et al., 1993; Williams & Koran, 1997) females in the luteal/premenstrual phase 
(days 17-highest) reported the highest levels of state anxiety.  In addition, females in the 
ovulatory phase, a phase normally associated with hindered performance on male-linked 
tasks (Kimura & Hampson, 1994), unexpectedly obtained the best targeting accuracy.   
As an extension of the primary research question, this study also explored the  
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relation between prenatal androgens and two other female-linked disorders: depression  
and borderline personality disorder.  Although the literature reports a female 
vulnerability for these two disorders (American Psychiatric Association, 2000), this 
study found no significant difference between males and females in reports of depressive 
or borderline symptoms, consistent with normalization data from the PAI (Morey, 1991).   
Furthermore, the relation between 2D:4D and depression has yielded inconsistent results 
in the literature.  While previous studies find no relation between 2D:4D and depression 
(Martin et al., 1999), recent findings suggest that men with higher digit ratios are more 
prone to a depressive personality style (Bailey & Hurd, 2005).  In support of the former, 
this study failed to find a significant relation between 2D:4D and depression.  It should 
be noted, however, that the depressive measures used in this study were designed to 
assess clinical, rather than trait depression. 
In contrast, results suggest a novel association between 2D:4D and borderline 
personality characteristics, affective instability in particular.  In fact, regression analyses 
reveal 2D:4D as the only significant predictor for the affective instability component of 
borderline personality. Individuals with a higher (i.e., more feminine) digit ratio reported 
greater irritability and shifts in mood than individuals with a lower (i.e., more masculine) 
digit ratio.  Like with anxiety, this effect was most prominent in males, suggesting that 
prenatal androgen effects on female-linked psychopathology may be more sensitive in 
men than in women.  Men with low prenatal androgen levels appear more vulnerable to 
borderline personality, while men with high prenatal androgen levels seem to be 
protected.  Given the relation between 2D:4D and borderline personality, activational 
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effects of circulating hormone levels were also expected.  This hypothesis, however, was 
not confirmed.  Contrary to previous research (DeSoto et al., 2003), borderline 
symptoms did not appear sensitive to estrogen and testosterone levels and did not seem  
to fluctuate across the menstrual cycle.  
 Though the present study has many strengths, such as the comprehensive 
measurement of anxiety through a broad array of measures, there were a number of 
limitations that may have influenced the general pattern of results.  One limitation of this 
study is the use of scanned copies to derive 2D:4D measurements.   The quality of the 
images may have distorted the accuracy of measurements leading to a non-significant 
sex difference in 2D:4D.  Future studies should incorporate direct measurements of the 
hand, as digit ratio measurements from hand copies may differ markedly from direct 
measurements (Manning, Fink, Neave, & Caswell, 2005).  Additionally, this study 
included both women who were and were not taking oral contraceptives, and personality 
and hormonal factors associated with the use of hormonal contraceptives may influence 
the magnitude of some hormone-behavior associations.  Finally, the large number of 
analyses and measures in this exploratory study may have yielded some illusory 
associations.  Future studies might benefit from including a smaller subset of variables 
and statistical analyses, or using a larger number of participants to gain statistical power.   
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SUMMARY AND CONCLUSIONS 
Despite its limitations, this study has replicated many of the common sex 
differences in behavior and provided further evidence for both organizational and 
activational hormone-behavior associations, particularly in the areas of spatial ability 
and gender role behavior.  More importantly, it has provided the first evidence that two 
female-linked disorders, anxiety and borderline personality, appear sensitive to the 
organizational effects of sex hormones.  Like previously studied male-typical (i.e., 
Tourette’s and autism) and female-typical (i.e., depression) psychopathology, 
(Alexander & Peterson, 2004; Bailey & Hurd, 2005; Manning et al. 2001), the 
expression of anxiety and borderline personality symptoms appears susceptible to levels 
of prenatal androgens.  Lower levels of prenatal androgens, such as those that occur in 
female development, may predispose individuals to anxiety and to borderline 
characteristics, such as affective instability, whereas higher levels of androgens appear to 
serve as a protective element against these two female disorders.   
Interestingly, organizational effects in this study appeared to be more prominent 
in males whereas activational effects were only evident in females.  This pattern of 
results lends itself to two primary explanations.  First, women may be more sensitive to 
fluctuations in adult sex hormones because as compared to men they experience greater 
fluctuations in hormone levels, for example across the menstrual cycle.  Second, 
organizational (i.e., 2D:4D) effects in relation to female-linked disorders may be easier 
to detect in men than in women, as women may be already predisposed towards these 
disorders.  Additionally, reports of psychopathology in women may be confounded by 
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activational hormone influences, such as the menstrual cycle and oral contraceptive use, 
making it more difficult to partial out the effects of prenatal and postnatal hormones.  
Nevertheless, it should be noted that though non-significant, there was a trend for 
females with higher 2D:4D to report greater borderline personality-affective instability 
symptoms and greater anxiety disorder symptoms in general.  It should also be noted that 
a smaller number of females than males were included in this study.  Perhaps if more 
females were included, organizational effects would have been equally found across men 
and women.  Despite being more prominent in males, the general results of this research 
suggest that prenatal androgens may play a significant role in the development of anxiety 
and borderline personality, in addition to the contribution of genetics (Hettema et al., 
2001; Kendler et al., 1995; Silove et al., 1995; Stein et al., 1999), neurotransmitters 
(Brawman-Mintzer & Lydiard, 1997; Charney et al., 1993; Nutt, 2000; Nutt et al., 1998; 
Pigott 2003), and gender role socialization (Arrindell et al., 1993; Chambless & Mason, 
1986; Eisler et al., 1988; Ginsburg & Silverman, 2000; Perez Blasco & Serra Desfilis, 
1997; Thornton & Leo, 1992).  Further research is needed to confirm our findings and 
extend them to a clinical sample.   
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APPENDIX A 
EXAMPLES OF SEX-LINKED SPATIAL TASKS 
 
Fig. A-1. Stimulus Card for Location Memory Task 
 
Fig. A-2. Response Card with Exchanged Objects 
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Fig. A-3. Diagram Representation of Spatial Working Memory Task 
 
 
 
 
Fig. A-4. Diagram Representation of Targeting Task 
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Fig. A-5. Sample Mental Rotation Problem 
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APPENDIX B 
 
CORRELATION MATRIX – DIGIT RATIO AND PSYCHOPATHOLOGY  
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97 
.071 
.488 
97 
.105 
.308 
97 
.339* 
.001 
97 
.385* 
.000 
97 
.184 
.071 
97 
ARD-P Pearson 
Sig. 
N 
.114 
.268 
97 
.417* 
.000 
97 
.461* 
.000 
97 
.458* 
.000 
97 
.606* 
.000 
97 
.712* 
.000 
97 
.694* 
.000 
97 
.701* 
.000 
97 
ARD-S Pearson 
Sig. 
N 
.069 
.504 
97 
.464* 
.000 
97 
.362* 
.000 
97 
.338* 
.001 
97 
.505* 
.000 
97 
.486* 
.000 
97 
.457* 
.000 
97 
.440* 
.000 
97 
DEP Pearson 
Sig. 
N 
.155 
.130 
97 
.809* 
.000 
97 
.646* 
.000 
97 
.615* 
.000 
97 
.752* 
.000 
97 
.721* 
.000 
97 
.621* 
.000 
97 
.615* 
.000 
97 
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 Digit 
Ratio 
BDI BAI STAI- 
State 
STAI- 
Trait 
ANX 
 
ANX-C 
 
ANX-A 
 
DEP-C 
 
 
Pearson 
Sig. 
N 
.140 
.172 
97 
.715* 
.000 
97 
.550* 
.000 
97 
.497* 
.000 
97 
.682* 
.000 
97 
.626* 
.000 
97 
.542* 
.000 
97 
.517* 
.000 
97 
DEP-A Pearson 
Sig. 
N 
.163 
.110 
97 
.821* 
.000 
97 
.674* 
.000 
97 
.670* 
.000 
97 
.737* 
.000 
97 
.701* 
.000 
97 
.619* 
.000 
97 
.588* 
.000 
97 
DEP-P Pearson 
Sig. 
N 
.099 
.335 
97 
.565* 
.000 
97 
.451* 
.000 
97 
.423* 
.000 
97 
.539* 
.000 
97 
.547* 
.000 
97 
.451* 
.000 
97 
.492* 
.000 
97 
BOR Pearson 
Sig. 
N 
.206* 
.043 
97 
.693* 
.000 
97 
.637* 
.000 
97 
.518* 
.000 
97 
.704* 
.000 
97 
.676* 
.000 
97 
.598* 
.000 
97 
.663* 
.000 
97 
BOR-A Pearson 
Sig. 
N 
.268* 
.008 
97 
.543* 
.000 
97 
.502* 
.000 
97 
.494* 
.000 
97 
.621* 
.000 
97 
.619* 
.000 
97 
.524* 
.000 
97 
.597* 
.000 
97 
BOR-I Pearson 
Sig. 
N 
.172 
.091 
97 
.734* 
.000 
97 
.657* 
.000 
97 
.498* 
.000 
97 
.661* 
.000 
97 
.669* 
.000 
97 
.637* 
.000 
97 
.627* 
.000 
97 
BOR-N Pearson 
Sig. 
N 
.148 
.149 
97 
.588* 
.000 
97 
.569* 
.000 
97 
.392* 
.000 
97 
.591* 
.000 
97 
.584* 
.000 
97 
.530* 
.000 
97 
.564* 
.000 
97 
BOR-S Pearson 
Sig. 
N 
.020 
.843 
97 
.302* 
.003 
97 
.249* 
.014 
97 
.227* 
.026 
97 
.326* 
.001 
97 
.192 
.059 
97 
.122 
.232 
97 
.263* 
.009 
97 
POMS – 
TMD 1 
Pearson 
Sig. 
N 
.043 
.676 
97 
.762* 
.000 
97 
.746* 
.000 
97 
.624* 
.000 
97 
.682* 
.000 
97 
.663* 
.000 
97 
.619* 
.000 
97 
.588* 
.000 
97 
POMS – 
TMD 2  
Pearson 
Sig. 
N 
.106 
.302 
97 
.598* 
.000 
97 
.591* 
.000 
97 
.686* 
.000 
97 
.695* 
.000 
97 
.642* 
.000 
97 
.585* 
.000 
97 
.627* 
.000 
97 
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 ANX-P ARD ARD-O ARD-P ARD-S DEP DEP-C DEP-A 
Digit  
Ratio         
Pearson 
Sig. 
N 
.091 
.373 
97 
.106 
.302 
97 
.058 
.575 
97 
.114 
.268 
97 
.069 
.504 
97 
.155 
.130 
97 
.140 
.172 
97 
.163 
.110 
97 
BDI           Pearson 
Sig. 
N 
.699* 
.000 
97 
.477* 
.000 
97 
.159 
.120 
97 
.417* 
.000 
97 
.464* 
.000 
97 
.809* 
.000 
97 
.715* 
.000 
97 
.821* 
.000 
97 
BAI           Pearson 
Sig. 
N 
.667* 
.000 
97 
.449* 
.000 
97 
.181 
.076 
97 
.461* 
.000 
97 
.362* 
.000 
97 
.646* 
.000 
97 
.550* 
.000 
97 
.674* 
.000 
97 
STAI-  
State        
Pearson 
Sig. 
N 
.537* 
.000 
97 
.386* 
.000 
97 
.071 
.488 
97 
.458* 
.000 
97 
.338* 
.001 
97 
.615* 
.000 
97 
.497* 
.000 
97 
.670* 
.000 
97 
STAI-     
Trait   
Pearson 
Sig. 
N 
.593* 
.000 
97 
.546* 
.000 
97 
.105 
.308 
97 
.606* 
.000 
97 
.505* 
.000 
97 
.752* 
.000 
97 
.682* 
.000 
97 
.737* 
.000 
97 
ANX Pearson 
Sig. 
N 
.874* 
.000 
97 
.683* 
.000 
97 
.339* 
.001 
97 
.712* 
.000 
97 
.486* 
.000 
97 
.721* 
.000 
97 
.626* 
.000 
97 
.701* 
.000 
97 
ANX-C Pearson 
Sig. 
N 
.741* 
.000 
97 
.681* 
.000 
97 
.385* 
.000 
97 
.694* 
.000 
97 
.457* 
.000 
97 
.621* 
.000 
97 
.542* 
.000 
97 
.619* 
.000 
97 
ANX-A Pearson 
Sig. 
N 
.684* 
.000 
97 
.584* 
.000 
97 
.184 
.071 
97 
.701* 
.000 
97 
.440* 
.000 
97 
.615* 
.000 
97 
.517* 
.000 
97 
.588* 
.000 
97 
ANX-P Pearson 
Sig. 
N 
1 
. 
97 
.585* 
.000 
97 
.335* 
.001 
97 
.539* 
.000 
97 
.430* 
.000 
97 
.759* 
.000 
97 
.672* 
.000 
97 
.726* 
.000 
97 
ARD 
 
Pearson 
Sig. 
N 
.585* 
.000 
97 
1 
. 
97 
.691* 
.000 
97 
.683* 
.000 
97 
.803* 
.000 
97 
.512* 
.000 
97 
.405* 
.000 
97 
.523* 
.000 
97 
ARD-O 
 
Pearson 
Sig. 
N 
.335* 
.001 
97 
.691* 
.000 
97 
1 
. 
97 
.230* 
.024 
97 
.284* 
.005 
97 
.132 
.197 
97 
.028 
.785 
97 
.155 
.130 
97 
ARD-P Pearson 
Sig. 
N 
.539* 
.000 
97 
.683* 
.000 
97 
.230* 
.024 
97 
1 
. 
97 
.375* 
.000 
97 
.492* 
.000 
97 
.442* 
.000 
97 
.505* 
.000 
97 
ARD-S Pearson 
Sig. 
N 
.430* 
.000 
97 
.803* 
.000 
97 
.284* 
.005 
97 
.375* 
.000 
97 
1 
. 
97 
.498* 
.000 
97 
.421* 
.000 
97 
.490* 
.000 
97 
DEP Pearson 
Sig. 
N 
.759* 
.000 
97 
.512* 
.000 
97 
.132 
.197 
97 
.492* 
.000 
97 
.498* 
.000 
97 
1 
. 
97 
.869* 
.000 
97 
.908* 
.000 
97 
DEP-C 
 
 
Pearson 
Sig. 
N 
.672* 
.000 
97 
.405* 
.000 
97 
.028 
.785 
97 
.442* 
.000 
97 
.421* 
.000 
97 
.869* 
.000 
97 
1 
. 
97 
.747* 
.000 
97 
DEP-A 
 
 
Pearson 
Sig. 
N 
.726* 
.000 
97 
.523* 
.000 
97 
.155 
.130 
97 
.505* 
.000 
97 
.490* 
.000 
97 
.908* 
.000 
97 
.747* 
.000 
97 
1 
. 
97 
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 ANX-P ARD ARD-O ARD-P ARD-S DEP DEP-C DEP-A 
DEP-P Pearson 
Sig. 
N 
.577* 
.000 
97 
.397* 
.000 
97 
.150 
.143 
97 
.331* 
.001 
97 
.382* 
.000 
97 
.826* 
.000 
97 
.542* 
.000 
97 
.601* 
.000 
97 
BOR Pearson 
Sig. 
N 
.600* 
.000 
97 
.543* 
.000 
97 
.104 
.310 
97 
.456* 
.000 
97 
.607* 
.000 
97 
.709* 
.000 
97 
.663* 
.000 
97 
.698* 
.000 
97 
BOR-A Pearson 
Sig. 
N 
.594* 
.000 
97 
.462* 
.000 
97 
.109 
.289 
97 
.373* 
.000 
97 
.510* 
.000 
97 
.626* 
.000 
97 
.571* 
.000 
97 
.593* 
.000 
97 
BOR-I Pearson 
Sig. 
N 
.560* 
.000 
97 
.544* 
.000 
97 
.196 
.055 
97 
.533* 
.000 
97 
.476* 
.000 
97 
.668* 
.000 
97 
.625* 
.000 
97 
.715* 
.000 
97 
BOR-N Pearson 
Sig. 
N 
.510* 
.000 
97 
.517* 
.000 
97 
.065 
.529 
97 
.440* 
.000 
97 
.603* 
.000 
97 
.608* 
.000 
97 
.538* 
.000 
97 
.590* 
.000 
97 
BOR-S Pearson 
Sig. 
N 
.161 
.115 
97 
.129 
.207 
97 
-.095 
.354 
97 
.008 
.941 
97 
.319* 
.001 
97 
.306* 
.000 
97 
.355* 
.000 
97 
.260* 
.010 
97 
POMS – 
TMD 1 
Pearson 
Sig. 
N 
.605* 
.000 
97 
.512* 
.000 
97 
.159 
.120 
97 
.403* 
.000 
97 
.540* 
.000 
97 
.688* 
.000 
97 
.595* 
.000 
97 
.749* 
.000 
97 
POMS – 
TMD 2  
Pearson 
Sig. 
N 
.547* 
.000 
97 
.527* 
.000 
97 
.144 
.158 
97 
.518* 
.000 
97 
.498* 
.000 
97 
.635* 
.000 
97 
.525* 
.000 
97 
.710* 
.000 
97 
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 DEP-P BOR BOR-A BOR-I BOR-N BOR-S POMS 
TMD-1 
POMS 
TMD-2 
Digit  
Ratio       
Pearson 
Sig. 
N 
.099 
.335 
97 
.206* 
.043 
97 
.268* 
.008 
97 
.172 
.091 
97 
.148 
.149 
97 
.020 
.843 
97 
.043 
.676 
97 
.106 
.302 
97 
BDI         Pearson 
Sig. 
N 
.565* 
.000 
97 
.693* 
.000 
97 
.543* 
.000 
97 
.734* 
.000 
97 
.588* 
.000 
97 
.302* 
.003 
97 
.762* 
.000 
97 
.598* 
.000 
97 
BAI         Pearson 
Sig. 
N 
.451* 
.000 
97 
.637* 
.000 
97 
.502* 
.000 
97 
.657* 
.000 
97 
.569* 
.000 
97 
.249* 
.014 
97 
.746* 
.000 
97 
.591* 
.000 
97 
STAI-  
State       
Pearson 
Sig. 
N 
.423* 
.000 
97 
.518* 
.000 
97 
.494* 
.000 
97 
.498* 
.000 
97 
.392* 
.000 
97 
.227* 
.026 
97 
.624* 
.000 
97 
.686* 
.000 
97 
STAI-     
Trait   
Pearson 
Sig. 
N 
.539* 
.000 
97 
.704* 
.000 
97 
.621* 
.000 
97 
.661* 
.000 
97 
.591* 
.000 
97 
.326* 
.001 
97 
.682* 
.000 
97 
.695* 
.000 
97 
ANX Pearson 
Sig. 
N 
.547* 
.000 
97 
.676* 
.000 
97 
.619* 
.000 
97 
.669* 
.000 
97 
.584* 
.000 
97 
.192 
.059 
97 
.663* 
.000 
97 
.642* 
.000 
97 
ANX-C Pearson 
Sig. 
N 
.451* 
.000 
97 
.598* 
.000 
97 
.524* 
.000 
97 
.637* 
.000 
97 
.530* 
.000 
97 
.122 
.232 
97 
.619* 
.000 
97 
.585* 
.000 
97 
ANX-A Pearson 
Sig. 
N 
.492* 
.000 
97 
.663* 
.000 
97 
.597* 
.000 
97 
.627* 
.000 
97 
.564* 
.000 
97 
.263* 
.009 
97 
.588* 
.000 
97 
.627* 
.000 
97 
ANX-P Pearson 
Sig. 
N 
.577* 
.000 
97 
.600* 
.000 
97 
.594* 
.000 
97 
.560* 
.000 
97 
.510* 
.000 
97 
.161 
.115 
97 
.605* 
.000 
97 
.547* 
.000 
97 
ARD 
 
Pearson 
Sig. 
N 
.397* 
.000 
97 
.543* 
.000 
97 
.462* 
.000 
97 
.544* 
.000 
97 
.517* 
.000 
97 
.129 
.207 
97 
.512* 
.000 
97 
.527* 
.000 
97 
ARD-O 
 
Pearson 
Sig. 
N 
.150 
.143 
97 
.104 
.310 
97 
.109 
.289 
97 
.196 
.055 
97 
.065 
.529 
97 
-.095 
.354 
97 
.159 
.120 
97 
.144 
.158 
97 
ARD-P Pearson 
Sig. 
N 
.331* 
.001 
97 
.456* 
.000 
97 
.373* 
.000 
97 
.533* 
.000 
97 
.440* 
.000 
97 
.008 
.941 
97 
.403* 
.000 
97 
.518* 
.000 
97 
ARD-S Pearson 
Sig. 
N 
.382* 
.000 
97 
.607* 
.000 
97 
.510* 
.000 
97 
.476* 
.000 
97 
.603* 
.000 
97 
.319* 
.001 
97 
.540* 
.000 
97 
.498* 
.000 
97 
DEP Pearson 
Sig. 
N 
.826* 
.000 
97 
.709* 
.000  
97 
.626* 
.000 
97 
.668* 
.000 
97 
.608* 
.000 
97 
.306* 
.002 
97 
.688* 
.000 
97 
.635* 
.000 
97 
DEP-C 
 
 
Pearson 
Sig. 
N 
.542* 
.000 
97 
.663* 
.000 
97 
.571* 
.000 
97 
.625* 
.000 
97 
.538* 
.000 
97 
.355* 
.000 
97 
.595* 
.000 
97 
.525* 
.000 
97 
DEP-A 
 
 
Pearson 
Sig. 
N 
.601* 
.000 
97 
.698* 
.000 
97 
.593* 
.000 
97 
.715* 
.000 
97 
.590* 
.000 
97 
.260* 
.010 
97 
.749* 
.000 
97 
.710* 
.000 
97 
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 DEP-P BOR BOR-A BOR-I BOR-N BOR-S POMS 
TMD-1 
POMS 
TMD-2 
DEP-P Pearson 
Sig. 
N 
1 
. 
97 
.488* 
.000 
97 
.465* 
.000 
97 
.395* 
.000 
97 
.453* 
.000 
97 
.191 
.060 
97 
.439* 
.000 
97 
.406* 
.000 
97 
BOR Pearson 
Sig. 
N 
.488* 
.000 
97 
1 
. 
97 
.886* 
.000 
97 
.834* 
.000 
97 
.852* 
.000 
97 
.594* 
.000 
97 
.753* 
.000 
97 
.698* 
.000 
97 
BOR-A Pearson 
Sig. 
N 
.465* 
.000 
97 
.886* 
.000 
97 
1 
. 
97 
.643* 
.000 
97 
.656* 
.000 
97 
.466* 
.000 
97 
.654* 
.000 
97 
.590* 
.000 
97 
BOR-I Pearson 
Sig. 
N 
.395* 
.000 
97 
.834* 
.000 
97 
.643* 
.000 
97 
1 
. 
97 
.638* 
.000 
97 
.307* 
.002 
97 
.674* 
.000 
97 
.650* 
.000 
97 
BOR-N Pearson 
Sig. 
N 
.453* 
.000 
97 
.852* 
.000 
97 
.656* 
.000 
97 
.638* 
.000 
97 
1 
. 
97 
.348* 
.000 
97 
.681* 
.000 
97 
.575* 
.000 
97 
BOR-S Pearson 
Sig. 
N 
.191 
.060 
97 
.594* 
.000 
97 
.466* 
.000 
97 
.307* 
.002 
97 
.348* 
.000 
97 
1 
. 
97 
.337* 
.001 
97 
.390* 
.000 
97 
POMS– 
TMD 1 
Pearson 
Sig. 
N 
.439* 
.000 
97 
.753* 
.000 
97 
.654* 
.000 
97 
.674* 
.000 
97 
.681* 
.000 
97 
.337* 
.001 
97 
1 
. 
97 
.776* 
.000 
97 
POMS– 
TMD 2  
Pearson 
Sig. 
N 
.406* 
.000 
97 
.698* 
.000 
97 
.590* 
.000 
97 
.650* 
.000 
97 
.575* 
.000 
97 
.390* 
.000 
97 
.776* 
.000 
97 
1 
. 
97 
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CORRELATION MATRIX – DIGIT RATIO AND SPATIAL TASKS 
 
 Digit  
Ratio 
Mental 
Rotation 
- 
# correct 
Targeting 
 
- 
Accuracy 
Location 
Memory  
- 
 Identity 
Location 
Memory 
- 
Location 
Spatial 
Memory 
- 
Errors 
Spatial 
Memory 
- 
Time 
Digit  
Ratio 
Pearson 
Sig. 
N 
1 
. 
110 
-.023 
.814 
110 
.176 
.066 
110 
-.189 
.090 
81 
-.002 
.987 
79 
.015 
.882 
105 
-.022 
.821 
106 
Mental 
Rotation 
Pearson 
Sig. 
N 
-.023 
.814 
110 
1 
. 
110 
-.362* 
.000 
110 
.118 
.294 
81 
.229* 
.042 
79 
-.016 
.875 
105 
-.145 
.138 
106 
Targeting Pearson 
Sig. 
N 
.176 
.066 
110 
-.362* 
.000 
110 
1 
. 
110 
.183 
.102 
81 
.094 
.411 
79 
-.053 
.595 
105 
-.019 
.849 
106 
Location 
Memory- 
Identity 
Pearson 
Sig. 
N 
-.189 
.090 
81 
.118 
.294 
81 
.183 
.102 
81 
1 
. 
81 
.546* 
.000 
79 
-.169 
.145 
76 
-.032 
.785 
77 
Location 
Memory- 
Location 
Pearson 
Sig. 
N 
-.002 
.987 
79 
.229* 
.042 
79 
.094 
.411 
79 
.546* 
.000 
79 
1 
. 
79 
-.141 
.230 
74 
-.159 
.172 
75 
Spatial 
Memory- 
Errors  
Pearson 
Sig. 
N 
.015 
.882 
105 
-.016 
.875 
105 
-.053 
.595 
105 
-.169 
.145 
76 
-.141 
.230 
74 
1 
. 
105 
.427* 
.000 
105 
Spatial 
Memory- 
Time 
Pearson 
Sig. 
N 
-.022 
.821 
106 
-.145 
.138 
106 
-.019 
.849 
106 
-.032 
.785 
77 
-.159 
.172 
75 
.427* 
.000 
105 
1 
. 
106 
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CORRELATION MATRIX – DIGIT RATIO AND GENDER ROLE MEASURES 
 
 Digit  
Ratio 
PSAI OAT-PM 
Masculine 
OAT-PM 
Feminine 
OAT-
AM 
BSRI 
Masculine 
BSRI 
Feminine 
Digit  
Ratio 
Pearson 
Sig. 
N 
1 
. 
110 
-.230* 
.015 
110 
-.154 
.133 
97 
.052 
.610 
97 
.034 
.742 
97 
-.175 
.087 
97 
.024 
.817 
97 
PSAI Pearson 
Sig. 
N 
-.230* 
.015 
110 
1 
. 
110 
.585* 
.000 
97 
-.588* 
.000 
97 
.353* 
.000 
97 
.323* 
.001 
97 
-.397* 
.000 
97 
OAT-PM 
Masculine 
Pearson 
Sig. 
N 
-.154 
.133 
97 
.585* 
.000 
97 
1 
. 
97 
-.172 
.092 
97 
.153 
.135 
97 
.272* 
.007 
97 
-.338* 
.001 
97 
OAT-PM 
Feminine 
Pearson 
Sig. 
N 
.052 
.610 
97 
-.588* 
.000 
97 
-.172 
.092 
97 
1 
. 
97 
-.137 
.182 
97 
-.095 
.354 
97 
.365* 
.000 
97 
OAT-AM Pearson 
Sig. 
N 
.034 
.742 
97 
.353* 
.000 
97 
.153 
.135 
97 
-.137 
.182 
97 
1 
. 
97 
.115 
.260 
97 
-.077 
.452 
97 
BSRI 
Masculine 
Pearson 
Sig. 
N 
-.175 
.087 
97 
.323* 
.001 
97 
.272* 
.007 
97 
-.095 
.354 
97 
.115 
.260 
97 
1 
. 
97 
-.078 
.445 
97 
BSRI 
Feminine 
Pearson 
Sig. 
N 
.024 
.817 
97 
-.397* 
.000 
97 
-.338* 
.001 
97 
.365* 
.000 
97 
-.077 
.452 
97 
-.078 
.445 
97 
1 
. 
97 
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CORRELATION MATRIX - PSYCHOPATHOLOGY MEASURES AND SPATIAL  
 
TASKS 
 
 Mental 
Rotation 
- 
# correct 
Targeting 
 
- 
Accuracy 
Location 
Memory  
- 
 Identity 
Location 
Memory 
- 
Location 
Spatial 
Memory 
- 
Errors 
Spatial 
Memory 
- 
Time 
BDI            Pearson 
Sig. 
N 
-.046 
.633 
110 
.073 
.447 
110 
.044 
.695 
81 
.017 
.883 
79 
-.017 
.862 
105 
-.079 
.420 
106 
BAI            Pearson 
Sig. 
N 
-.152 
.137 
97 
.140 
.171 
97 
.033 
.781 
73 
-.099 
.410 
71 
.039 
.710 
92 
-.039 
.713 
93 
STAI-  
State        
Pearson 
Sig. 
N 
-.082 
.397 
110 
.080 
.405 
110 
.101 
.371 
81 
-.007 
.952 
79 
.126 
.201 
105 
.006 
.953 
106 
STAI-     
Trait   
Pearson 
Sig. 
N 
-.192* 
.045 
110 
.213* 
.026 
110 
-.048 
.671 
81 
-.020 
.859 
79 
.114 
.246 
105 
.015 
.877 
106 
ANX Pearson 
Sig. 
N 
-.328* 
.001 
97 
.225* 
.027 
97 
-.047 
.694 
73 
-.039 
.747 
71 
.097 
.357 
92 
.073 
.488 
93 
ANX-C Pearson 
Sig. 
N 
-.311* 
.002 
97 
.238* 
.019 
97 
-.021 
.861 
73 
-.110 
.361 
71 
.081 
.444 
92 
.068 
.519 
93 
ANX-A Pearson 
Sig. 
N 
-.378* 
.000 
97 
.245* 
.016 
97 
-.121 
.306 
73 
-.012 
.919 
71 
.143 
.174 
92 
.086 
.411 
93 
ANX-P 
 
 
Pearson 
Sig. 
N 
-.203* 
.046 
97 
.121 
.238 
97 
.003 
.981 
73 
.046 
.706 
71 
.044 
.676 
92 
.045 
.671 
93 
ARD 
 
 
Pearson 
Sig. 
N 
-.192 
.060 
97 
-.020 
.846 
97 
-.016 
.894 
73 
-.028 
.815 
71 
.052 
.622 
92 
.130 
.214 
93 
ARD-O 
 
 
Pearson 
Sig. 
N 
-.006 
.951 
97 
-.061 
.556 
97 
.124 
.296 
73 
-.047 
.695 
71 
-.025 
.813 
92 
.145 
.167 
93 
ARD-P 
 
 
Pearson 
Sig. 
N 
-.284* 
.005 
97 
.154 
.131 
97 
.072 
.545 
73 
-.051 
.673 
71 
.172 
.101 
92 
.195 
.061 
93 
ARD-S 
 
 
Pearson 
Sig. 
N 
-.152 
.137 
97 
-.096 
.349 
97 
-.188 
.111 
73 
.030 
.804 
71 
-.005 
.962 
92 
-.018 
.864 
93 
DEP 
 
 
Pearson 
Sig. 
N 
-.080 
.438 
97 
.062 
.548 
97 
.009 
.943 
73 
.121 
.316 
71 
.094 
.372 
92 
-.002 
.986 
93 
DEP-C 
 
 
Pearson 
Sig. 
N 
.007 
.947 
97 
-.011 
.913 
97 
.010 
.932 
73 
.135 
.261 
71 
.105 
.318 
92 
-.029 
.786 
93 
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 Mental 
Rotation 
- 
# correct 
Targeting 
 
- 
Accuracy 
Location 
Memory  
- 
 Identity 
Location 
Memory 
- 
Location 
Spatial 
Memory 
- 
Errors 
Spatial 
Memory 
- 
Time 
DEP-A 
 
 
Pearson 
Sig. 
N 
-.002 
.984 
97 
.024 
.815 
97 
.008 
.946 
73 
.093 
.443 
71 
.073 
.488 
92 
-.026 
.802 
93 
DEP-P Pearson 
Sig. 
N 
-.209* 
.040 
97 
.144 
.161 
97 
.005 
.969 
73 
.097 
.423 
71 
.067 
.526 
92 
.052 
.621 
93 
BOR Pearson 
Sig. 
N 
-.112 
.275 
97 
.081 
.431 
97 
-.138 
.244 
73 
.101 
.402 
71 
.083 
.433 
92 
-.107 
.306 
93 
BOR-A Pearson 
Sig. 
N 
-.108 
.291 
97 
.091 
.375 
97 
-.197 
.095 
73 
.024 
.842 
71 
.188 
.072 
92 
.010 
.922 
93 
BOR-I Pearson 
Sig. 
N 
-.029 
.780 
97 
.040 
.699 
97 
-.050 
.675 
73 
.066 
.582 
71 
.013 
.899 
92 
-.130 
.212 
93 
BOR-N Pearson 
Sig. 
N 
-.162 
.113 
97 
.111 
.277 
97 
-.100 
.399 
73 
.147 
.220 
71 
.053 
.615 
92 
-.163 
.118 
93 
BOR-S Pearson 
Sig. 
N 
-.043 
.676 
97 
-.011 
.916 
97 
-.083 
.485 
73 
.096 
.427 
71 
-.028 
.794 
92 
-.064 
.543 
93 
POMS– 
TMD 1 
Pearson 
Sig. 
N 
.028 
.784 
97 
-.012 
.911 
97 
-.108 
.365 
73 
-.117 
.332 
71 
.052 
.623 
92 
-.101 
.337 
93 
POMS– 
TMD 2  
Pearson 
Sig. 
N 
-.133 
.195 
97 
.030 
.773 
97 
-.121 
.307 
73 
-.212 
.076 
71 
.123 
.242 
92 
-.003 
.976 
93 
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CORRELATION MATRIX – PSYCHOPATHOLOGY MEASURES AND GENDER  
 
ROLE MEASURES 
 
 PSAI OAT-PM 
Masculine 
OAT-PM 
Feminine 
OAT-
AM 
BSRI 
Masculine 
BSRI 
Feminine 
BDI            Pearson 
Sig. 
N 
-.148 
.123 
110 
-.026 
.804 
97 
.070 
.495 
97 
-.023 
.825 
97 
-.217* 
.033 
97 
.037 
.717 
97 
BAI            Pearson 
Sig. 
N 
-.207* 
.042 
97 
-.008 
.938 
97 
.119 
.246 
97 
-.127 
.216 
97 
-.120 
.243 
97 
-.013 
.901 
97 
STAI-  
State        
Pearson 
Sig. 
N 
-.092 
.339 
110 
-.063 
.540 
97 
.024 
.819 
97 
-.021 
.836 
97 
-.105 
.305 
97 
.003 
.975 
97 
STAI-     
Trait   
Pearson 
Sig. 
N 
-.159 
.098 
110 
-.093 
.365 
97 
.066 
.518 
97 
-.010 
.919 
97 
-.310* 
.002 
97 
.065 
.525 
97 
ANX Pearson 
Sig. 
N 
-.306* 
.002 
97 
-.112 
.275 
97 
.179 
.079 
97 
-.045 
.665 
97 
-.250* 
.013 
97 
.088 
.394 
97 
ANX-C Pearson 
Sig. 
N 
-.278* 
.006 
97 
-.124 
.225 
97 
.182 
.074 
97 
-.036 
.726 
97 
-.208* 
.041 
97 
.119 
.246 
97 
ANX-A Pearson 
Sig. 
N 
-.316* 
.002 
97 
-.145 
.157 
97 
.192 
.060 
97 
-.060 
.560 
97 
-.302* 
.003 
97 
.120 
.242 
97 
ANX-P 
 
 
Pearson 
Sig. 
N 
-.244* 
.016 
97 
-.028 
.788 
97 
.110 
.283 
97 
-.027 
.790 
97 
-.184 
.072 
97 
-.016 
.880 
97 
ARD 
 
 
Pearson 
Sig. 
N 
-.180 
.078 
97 
-.056 
.587 
97 
.214* 
.035 
97 
.031 
.762 
97 
-.176 
.085 
97 
.039 
.706 
97 
ARD-O 
 
 
Pearson 
Sig. 
N 
-.145 
.157 
97 
-.049 
.637 
97 
.313* 
.002 
97 
.108 
.294 
97 
-.078 
.445 
97 
.032 
.759 
97 
ARD-P 
 
 
Pearson 
Sig. 
N 
-.298* 
.003 
97 
-.164 
.109 
97 
.138 
.176 
97 
-.058 
.571 
97 
-.323* 
.001 
97 
.245* 
.016 
97 
ARD-S 
 
 
Pearson 
Sig. 
N 
-.001 
.990 
97 
.054 
.603 
97 
.038 
.712 
97 
.009 
.933 
97 
-.033 
.748 
97 
-.129 
.208 
97 
DEP 
 
 
Pearson 
Sig. 
N 
-.082 
.422 
97 
-.046 
.655 
97 
-.067 
.514 
97 
-.049 
.633 
97 
-.239* 
.019 
97 
-.085 
.409 
97 
DEP-C 
 
 
Pearson 
Sig. 
N 
-.006 
.951 
97 
.003 
.976 
97 
-.172 
.091 
97 
-.020 
.844 
97 
-.247* 
.015 
97 
-.022 
.829 
97 
DEP-A 
 
 
Pearson 
Sig. 
N 
-.071 
.489 
97 
-.096 
.352 
97 
-.083 
.418 
97 
-.043 
.678 
97 
-.240* 
.018 
97 
-.145 
.156 
97 
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 PSAI OAT-PM 
Masculine 
OAT-PM 
Feminine 
OAT-
AM 
BSRI 
Masculine 
BSRI 
Feminine 
DEP-P Pearson 
Sig. 
N 
-.131 
.201 
97 
-.019 
.852 
97 
.071 
.490 
97 
-.063 
.542 
97 
-.136 
.184 
97 
-.044 
.670 
97 
BOR Pearson 
Sig. 
N 
-.069 
.504 
97 
-.004 
.969 
97 
-.052 
.612 
97 
-.056 
.584 
97 
-.131 
.201 
97 
-.037 
.718 
97 
BOR-A Pearson 
Sig. 
N 
-.072 
.484 
97 
.010 
.921 
97 
-.025 
.809 
97 
-.053 
.603 
97 
-.091 
.375 
97 
-.158 
.121 
97 
BOR-I Pearson 
Sig. 
N 
-.075 
.468 
97 
-.116 
.256 
97 
-.081 
.433 
97 
-.059 
.567 
97 
-.253* 
.012 
97 
.029 
.778 
97 
BOR-N Pearson 
Sig. 
N 
-.117 
.253 
97 
.030 
.772 
97 
.008 
.940 
97 
-.084 
.413 
97 
-.084 
.411 
97 
.030 
.773 
97 
BOR-S Pearson 
Sig. 
N 
.099 
.333 
97 
.095 
.357 
97 
-.095 
.356 
97 
.049 
.631 
97 
.057 
.576 
97 
.002 
.985 
97 
POMS– 
TMD 1 
Pearson 
Sig. 
N 
-.058 
.574 
97 
.055 
.590 
97 
-.004 
.972 
97 
-.059 
.564 
97 
-.093 
.366 
97 
-.143 
.161 
97 
POMS– 
TMD 2  
Pearson 
Sig. 
N 
-.059 
.565 
97 
-.019 
.850 
97 
-.036 
.728 
97 
.033 
.746 
97 
-.174 
.087 
97 
-.076 
.458 
97 
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CORRELATION MATRIX – GENDER ROLE MEASURES AND SPATIAL TASKS 
 
 Mental 
Rotation 
- 
# correct 
Targeting 
 
- 
Accuracy 
Location 
Memory  
- 
 Identity 
Location 
Memory 
- 
Location 
Spatial 
Memory 
- 
Errors 
Spatial 
Memory 
- 
Time 
PSAI Pearson 
Sig. 
N 
.381* 
.000 
110 
-.544* 
.000 
110 
-.068 
.544 
81 
-.083 
.467 
79 
.044 
.659 
105 
.023 
.817 
106 
OAT-PM 
Masculine 
Pearson 
Sig. 
N 
.245* 
.016 
97 
-.234* 
.021 
97 
.119 
.316 
73 
.043 
.724 
71 
.063 
.551 
92 
.051 
.629 
93 
OAT-PM 
Feminine 
Pearson 
Sig. 
N 
-.385* 
.000 
97 
.389* 
.000 
97 
.025 
.835 
73 
-.050 
.676 
71 
.036 
.732 
92 
.201 
.053 
93 
OAT-AM Pearson 
Sig. 
N 
.096 
.347 
97 
-.219* 
.031 
97 
-.112 
.347 
73 
-.176 
.143 
71 
-.003 
.974 
92 
.284* 
.006 
93 
BSRI 
Masculine 
Pearson 
Sig. 
N 
.141 
.169 
97 
-.099 
.332 
97 
.075 
.528 
73 
-.060 
.619 
71 
-.108 
.304 
92 
-.218* 
.036 
93 
BSRI 
Feminine 
Pearson 
Sig. 
N 
-.221* 
.029 
97 
.300* 
.003 
97 
.157 
.184 
73 
.079 
.513 
71 
-.032 
.759 
92 
.013 
.900 
93 
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CORRELATION MATRIX – HORMONE LEVELS AND PSYCHOPATHOLOGY  
 
MEASURES 
 
Males 
 
 BDI BAI STAI- 
State 
STAI- 
Trait 
ANX 
 
ANX-C 
 
ANX-A 
 
Average 
Testosterone  
Pearson 
Sig. 
N 
-.032 
.809 
58 
-.010 
.945 
54 
.159 
.232 
58 
.011 
.937 
58 
.026 
.850 
54 
.101 
.469 
54 
.012 
.932 
54 
 
 ANX-P ARD ARD-O ARD-P ARD-S DEP DEP-C 
Average 
Testosterone  
Pearson 
Sig. 
N 
-.076 
.585 
54 
-.011 
.937 
54 
-.102 
.464 
54 
.027 
.844 
54 
.043 
.757 
54 
.044 
.752 
54 
.056 
.688 
54 
 
 DEP-A DEP-P BOR BOR-A BOR-I BOR-N BOR-S 
Average 
Testosterone  
Pearson 
Sig. 
N 
-.024 
.866 
54 
.089 
.520 
54 
-.008 
.953 
54 
-.024 
.865 
54 
-.001 
.992 
54 
.149 
.283 
54 
-.216 
.117 
54 
 
 POMS 
TMD-1 
POMS 
TMD-2 
Average 
Testosterone  
Pearson 
Sig. 
N 
.108 
.437 
54 
-.008 
.955 
54 
 
 
Females Not Taking Oral Contraceptives  
 
 BDI BAI STAI- 
State 
STAI- 
Trait 
ANX 
 
ANX-C 
 
ANX-A 
 
Average 
Estradiol  
Pearson 
Sig. 
N 
.280 
.115 
33 
.141 
.483 
27 
.158 
.380 
33 
.173 
.336 
33 
-.248 
.213 
27 
-.309 
.117 
27 
-.285 
.150 
27 
Average 
Testosterone  
Pearson 
Sig. 
N 
.137 
.420 
37 
.338 
.063 
31 
-.118 
.485 
37 
-.165 
.328 
37 
.053 
.776 
31 
.070 
.710 
31 
-.040 
.833 
31 
 
 ANX-P ARD ARD-O ARD-P ARD-S DEP DEP-C 
Average 
Estradiol  
Pearson 
Sig. 
N 
-.080 
.693 
27 
-.279 
.159 
27 
-.331 
.092 
27 
-.122 
.543 
27 
-.160 
.425 
27 
-.027 
.895 
27 
.001 
.997 
27 
Average 
Testosterone  
Pearson 
Sig. 
N 
.092 
.622 
31 
-.096 
.607 
31 
-.012 
.949 
31 
-.004 
.981 
31 
-.159 
.393 
31 
.112 
.548 
31 
-.036 
.847 
31 
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 DEP-A DEP-P BOR BOR-A BOR-I BOR-N BOR-S 
Average 
Estradiol 
Pearson 
Sig. 
N 
.048 
.810 
27 
-.165 
.410 
27 
.107 
.594 
27 
.030 
.881 
27 
.330 
.093 
27 
-.105 
.603 
27 
.120 
.552 
27 
Average 
Testosterone 
Pearson 
Sig. 
N 
.136 
.466 
31 
.203 
.274 
31 
.054 
.774 
31 
.031 
.870 
31 
.037 
.844 
31 
.161 
.386 
31 
-.163 
.382 
31 
 
 
 POMS 
TMD-1 
POMS 
TMD-2 
Average 
Estradiol 
Pearson 
Sig. 
N 
.074 
.713 
27 
-.030 
.882 
27 
Average 
Testosterone 
Pearson 
Sig. 
N 
.176 
.342 
31 
.088 
.638 
31 
 
 
CORRELATION MATRIX – HORMONE LEVELS AND SPATIAL TASKS 
 
Males 
 
 Mental 
Rotation 
- 
# correct 
Targeting 
 
- 
Accuracy 
Location 
Memory  
- 
 Identity 
Location 
Memory 
- 
Location 
Spatial 
Memory 
 - 
Errors 
Spatial 
Memory 
- 
Time 
Average 
Testosterone  
Pearson 
Sig. 
N 
.022 
.869 
58 
.023 
.864 
58 
-.012 
.938 
42 
.012 
.942 
41 
-.167 
.222 
55 
-.091 
.504 
56 
 
 
Females Not Taking Oral Contraceptives  
 
 Mental 
Rotation 
- 
# correct 
Targeting 
 
- 
Accuracy 
Location 
Memory  
- 
 Identity 
Location 
Memory 
- 
Location 
Spatial 
Memory 
 - 
Errors 
Spatial 
Memory 
- 
Time 
Average 
Estradiol  
Pearson 
Sig. 
N 
.417* 
.016 
33 
.161 
.371 
33 
.172 
.401 
26 
.041 
.847 
25 
-.356* 
.049 
31 
-.308 
.092 
31 
Average 
Testosterone  
Pearson 
Sig. 
N 
-.007 
.966 
37 
-.099 
.561 
37 
-.373 
.056 
27 
-.534* 
.005 
26 
.011 
.952 
35 
.006 
.974 
35 
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CORRELATION MATRIX – HORMONE LEVELS AND GENDER ROLE  
 
MEASURES 
 
Males 
 
 PSAI OAT-PM 
Masculine 
OAT-PM 
Feminine 
OAT-AM BSRI 
Masculine 
BSRI 
Feminine 
Average 
Testosterone  
Pearson 
Sig. 
N 
.083 
.534 
58 
-.106 
.446 
54 
.206 
.136 
54 
-.074 
.593 
54 
.118 
.397 
54 
.161 
.245 
54 
 
 
Females Not Taking Oral Contraceptives 
 
 PSAI OAT-PM 
Masculine 
OAT-PM 
Feminine 
OAT-AM BSRI 
Masculine 
BSRI 
Feminine 
Average 
Estradiol 
Pearson 
Sig. 
N 
-.242 
.175 
33 
-.015 
.940 
27 
.017 
.932 
27 
-.194 
.332 
27 
-.026 
.899 
27 
-.085 
.672 
27 
Average 
Testosterone  
Pearson 
Sig. 
N 
.132 
.437 
37 
.358* 
.048 
31 
-.061 
.746 
31 
.009 
.962 
31 
.159 
.394 
31 
-.450* 
.011 
31 
 
 
 
CORRELATION MATRIX – DIGIT RATIO AND HORMONE LEVELS 
 
Males 
 
 Digit 
Ratio 
Average 
Testosterone  
Pearson 
Sig. 
N 
.149 
.264 
58 
 
 
Females Not Taking Oral Contraceptives 
 
 Digit 
Ratio 
Average 
Estradiol 
 
Pearson 
Sig. 
N 
.155 
.389 
33 
Average 
Testosterone  
Pearson 
Sig. 
N 
.060 
.725 
37 
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